{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:36:46Z","timestamp":1794278206460,"version":"4.9.0"},"reference-count":315,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T00:00:00Z","timestamp":1636502400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Neurol"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41582-021-00577-7","type":"journal-article","created":{"date-parts":[[2021,11,10]],"date-time":"2021-11-10T06:05:20Z","timestamp":1636524320000},"page":"7-24","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":254,"title":["Circadian rhythms in neurodegenerative disorders"],"prefix":"10.1038","volume":"18","author":[{"given":"Malik","family":"Nassan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9237-1516","authenticated-orcid":false,"given":"Aleksandar","family":"Videnovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,10]]},"reference":[{"key":"577_CR1","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev-neuro-060909-153128","volume":"35","author":"JA Mohawk","year":"2012","unstructured":"Mohawk, J. A., Green, C. B. & Takahashi, J. S. Central and peripheral circadian clocks in mammals. Annu. Rev. Neurosci. 35, 445\u2013462 (2012).","journal-title":"Annu. Rev. Neurosci."},{"key":"577_CR2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41580-019-0179-2","volume":"21","author":"A Patke","year":"2020","unstructured":"Patke, A., Young, M. W. & Axelrod, S. Molecular mechanisms and physiological importance of circadian rhythms. Nat. Rev. Mol. Cell Biol. 21, 67\u201384 (2020). A review of the molecular mechanisms of circadian rhythms.","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"577_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/jnc.15012","volume":"157","author":"D Ono","year":"2021","unstructured":"Ono, D., Honma, K. I. & Honma, S. GABAergic mechanisms in the suprachiasmatic nucleus that influence circadian rhythm. J. Neurochem. 157, 31\u201341 (2021).","journal-title":"J. Neurochem."},{"key":"577_CR4","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1177\/074873048800300106","volume":"3","author":"VM Cassone","year":"1988","unstructured":"Cassone, V. M., Speh, J. C., Card, J. P. & Moore, R. Y. Comparative anatomy of the mammalian hypothalamic suprachiasmatic nucleus. J. Biol. Rhythm. 3, 71\u201391 (1988).","journal-title":"J. Biol. Rhythm."},{"key":"577_CR5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0006-8993(85)91350-2","volume":"342","author":"DF Swaab","year":"1985","unstructured":"Swaab, D. F., Fliers, E. & Partiman, T. S. The suprachiasmatic nucleus of the human brain in relation to sex, age and senile dementia. Brain Res. 342, 37\u201344 (1985).","journal-title":"Brain Res."},{"key":"577_CR6","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1152\/physrev.00009.2009","volume":"90","author":"DA Golombek","year":"2010","unstructured":"Golombek, D. A. & Rosenstein, R. E. Physiology of circadian entrainment. Physiol. Rev. 90, 1063\u20131102 (2010).","journal-title":"Physiol. Rev."},{"key":"577_CR7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1080\/07420520701283693","volume":"24","author":"H Dardente","year":"2007","unstructured":"Dardente, H. & Cermakian, N. Molecular circadian rhythms in central and peripheral clocks in mammals. Chronobiol. Int. 24, 195\u2013213 (2007).","journal-title":"Chronobiol. Int."},{"key":"577_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-396971-2.00001-4","volume":"119","author":"RY Moore","year":"2013","unstructured":"Moore, R. Y. The suprachiasmatic nucleus and the circadian timing system. Prog. Mol. Biol. Transl. Sci. 119, 1\u201328 (2013).","journal-title":"Prog. Mol. Biol. Transl. Sci."},{"key":"577_CR9","first-page":"327","volume":"92","author":"AJ Brown","year":"2019","unstructured":"Brown, A. J., Pendergast, J. S. & Yamazaki, S. Peripheral circadian oscillators. Yale J. Biol. Med. 92, 327\u2013335 (2019). A review of peripheral circadian clocks.","journal-title":"Yale J. Biol. Med."},{"key":"577_CR10","doi-asserted-by":"crossref","first-page":"eaao0318","DOI":"10.1126\/science.aao0318","volume":"359","author":"LS Mure","year":"2018","unstructured":"Mure, L. S. et al. Diurnal transcriptome atlas of a primate across major neural and peripheral tissues. Science 359, eaao0318 (2018).","journal-title":"Science"},{"key":"577_CR11","doi-asserted-by":"crossref","first-page":"16219","DOI":"10.1073\/pnas.1408886111","volume":"111","author":"R Zhang","year":"2014","unstructured":"Zhang, R., Lahens, N. F., Ballance, H. I., Hughes, M. E. & Hogenesch, J. B. A circadian gene expression atlas in mammals: implications for biology and medicine. Proc. Natl Acad. Sci. USA 111, 16219\u201316224 (2014).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"577_CR12","doi-asserted-by":"crossref","first-page":"17013","DOI":"10.1038\/nrdp.2017.13","volume":"3","author":"W Poewe","year":"2017","unstructured":"Poewe, W. et al. Parkinson disease. Nat. Rev. Dis. Prim. 3, 17013 (2017).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"577_CR13","doi-asserted-by":"crossref","first-page":"404","DOI":"10.5694\/mja17.00993","volume":"208","author":"N Titova","year":"2018","unstructured":"Titova, N. & Chaudhuri, K. R. Non-motor Parkinson disease: new concepts and personalised management. Med. J. Aust. 208, 404\u2013409 (2018).","journal-title":"Med. J. Aust."},{"key":"577_CR14","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/mds.26509","volume":"31","author":"A Videnovic","year":"2016","unstructured":"Videnovic, A. & Willis, G. L. Circadian system \u2014 a novel diagnostic and therapeutic target in Parkinson\u2019s disease? Mov. Disord. 31, 260\u2013269 (2016).","journal-title":"Mov. Disord."},{"key":"577_CR15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.parkreldis.2019.02.041","volume":"63","author":"DJ van Wamelen","year":"2019","unstructured":"van Wamelen, D. J. et al. Slave to the rhythm: Seasonal differences in non-motor symptoms in Parkinson\u2019s disease. Parkinsonism Relat. Disord. 63, 73\u201376 (2019).","journal-title":"Parkinsonism Relat. Disord."},{"key":"577_CR16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fncel.2017.00091","volume":"11","author":"KS Korshunov","year":"2017","unstructured":"Korshunov, K. S., Blakemore, L. J. & Trombley, P. Q. Dopamine: a modulator of circadian rhythms in the central nervous system. Front. Cell Neurosci. 11, 91 (2017).","journal-title":"Front. Cell Neurosci."},{"key":"577_CR17","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3390\/cells9020314","volume":"9","author":"A Vallee","year":"2020","unstructured":"Vallee, A., Lecarpentier, Y., Guillevin, R. & Vallee, J. N. Circadian rhythms, neuroinflammation and oxidative stress in the story of Parkinson\u2019s disease. Cells 9, 314 (2020).","journal-title":"Cells"},{"key":"577_CR18","doi-asserted-by":"crossref","first-page":"105029","DOI":"10.1016\/j.nbd.2020.105029","volume":"144","author":"K Fifel","year":"2020","unstructured":"Fifel, K. & Videnovic, A. Circadian alterations in patients with neurodegenerative diseases: neuropathological basis of underlying network mechanisms. Neurobiol. Dis. 144, 105029 (2020). This review outlines the neuropathological basis of circadian dysregulation in common neurodegenerative disorders.","journal-title":"Neurobiol. Dis."},{"key":"577_CR19","first-page":"1299","volume":"34","author":"G Esquiva","year":"2019","unstructured":"Esquiva, G. & Hannibal, J. Melanopsin-expressing retinal ganglion cells in aging and disease. Histol. Histopathol. 34, 1299\u20131311 (2019).","journal-title":"Histol. Histopathol."},{"key":"577_CR20","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s40478-018-0596-z","volume":"6","author":"I Ortuno-Lizaran","year":"2018","unstructured":"Ortuno-Lizaran, I. et al. Degeneration of human photosensitive retinal ganglion cells may explain sleep and circadian rhythms disorders in Parkinson\u2019s disease. Acta Neuropathol. Commun. 6, 90 (2018). This study revealed changes in retinal ganglion cells in individuals with PD; these cells are an important component of the circadian system.","journal-title":"Acta Neuropathol. Commun."},{"key":"577_CR21","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3389\/fneur.2017.00162","volume":"8","author":"C La Morgia","year":"2017","unstructured":"La Morgia, C., Ross-Cisneros, F. N., Sadun, A. A. & Carelli, V. Retinal ganglion cells and circadian rhythms in Alzheimer\u2019s disease, Parkinson\u2019s disease, and beyond. Front. Neurol. 8, 162 (2017).","journal-title":"Front. Neurol."},{"key":"577_CR22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-26078-0","volume":"8","author":"DS Joyce","year":"2018","unstructured":"Joyce, D. S., Feigl, B., Kerr, G., Roeder, L. & Zele, A. J. Melanopsin-mediated pupil function is impaired in Parkinson\u2019s disease. Sci. Rep. 8, 7796 (2018).","journal-title":"Sci. Rep."},{"key":"577_CR23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fneur.2019.00360","volume":"10","author":"PS Chougule","year":"2019","unstructured":"Chougule, P. S., Najjar, R. P., Finkelstein, M. T., Kandiah, N. & Milea, D. Light-induced pupillary responses in Alzheimer\u2019s disease. Front. Neurol. 10, 360 (2019).","journal-title":"Front. Neurol."},{"key":"577_CR24","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1001\/jamaneurol.2013.6239","volume":"71","author":"A Videnovic","year":"2014","unstructured":"Videnovic, A. et al. Circadian melatonin rhythm and excessive daytime sleepiness in Parkinson disease. JAMA Neurol. 71, 463\u2013469 (2014). This study revealed a diminished amplitude of melatonin rhythm in individuals with moderate PD.","journal-title":"JAMA Neurol."},{"key":"577_CR25","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/jamaneurol.2014.65","volume":"71","author":"DP Breen","year":"2014","unstructured":"Breen, D. P. et al. Sleep and circadian rhythm regulation in early Parkinson disease. JAMA Neurol. 71, 589\u2013595 (2014). This study revealed diminished amplitude of melatonin rhythm and clock gene expression in patients with early-stage PD.","journal-title":"JAMA Neurol."},{"key":"577_CR26","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1001\/jamaneurol.2018.0640","volume":"75","author":"E De Pablo-Fernandez","year":"2018","unstructured":"De Pablo-Fernandez, E., Courtney, R., Warner, T. T. & Holton, J. L. A Histologic study of the circadian system in Parkinson disease, multiple system atrophy, and progressive supranuclear palsy. JAMA Neurol. 75, 1008\u20131012 (2018).","journal-title":"JAMA Neurol."},{"key":"577_CR27","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jnnp.54.1.91","volume":"54","author":"PH Critchley","year":"1991","unstructured":"Critchley, P. H. et al. Fatigue and melatonin in Parkinson\u2019s disease. J. Neurol. Neurosurg. Psychiatry 54, 91\u201392 (1991).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"577_CR28","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1212\/01.wnl.0000183056.89590.0d","volume":"65","author":"RD Abbott","year":"2005","unstructured":"Abbott, R. D. et al. Excessive daytime sleepiness and subsequent development of Parkinson disease. Neurology 65, 1442\u20131446 (2005).","journal-title":"Neurology"},{"key":"577_CR29","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1093\/brain\/awz030","volume":"142","author":"RB Postuma","year":"2019","unstructured":"Postuma, R. B. et al. Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study. Brain 142, 744\u2013759 (2019).","journal-title":"Brain"},{"key":"577_CR30","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.sleep.2021.06.023","volume":"85","author":"K Obayashi","year":"2021","unstructured":"Obayashi, K. et al. Circadian activity rhythm in Parkinson\u2019s disease: findings from the PHASE study. Sleep Med. 85, 8\u201314 (2021).","journal-title":"Sleep Med."},{"key":"577_CR31","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1109\/86.650297","volume":"5","author":"EJ Van Someren","year":"1997","unstructured":"Van Someren, E. J. Actigraphic monitoring of movement and rest-activity rhythms in aging, Alzheimer\u2019s disease, and Parkinson\u2019s disease. IEEE Trans. Rehabil. Eng. 5, 394\u2013398 (1997).","journal-title":"IEEE Trans. Rehabil. Eng."},{"key":"577_CR32","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1080\/07420528.2020.1715998","volume":"37","author":"C Brooks","year":"2020","unstructured":"Brooks, C. et al. Variations in rest-activity rhythm are associated with clinically measured disease severity in Parkinson\u2019s disease. Chronobiol. Int. 37, 699\u2013711 (2020).","journal-title":"Chronobiol. Int."},{"key":"577_CR33","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cger.2019.09.005","volume":"36","author":"P Gros","year":"2020","unstructured":"Gros, P. & Videnovic, A. Overview of sleep and circadian rhythm disorders in parkinson disease. Clin. Geriatr. Med. 36, 119\u2013130 (2020).","journal-title":"Clin. Geriatr. Med."},{"key":"577_CR34","first-page":"271","volume":"92","author":"RM Grippo","year":"2019","unstructured":"Grippo, R. M. & Guler, A. D. Dopamine signaling in circadian photoentrainment: consequences of desynchrony. Yale J. Biol. Med. 92, 271\u2013281 (2019).","journal-title":"Yale J. Biol. Med."},{"key":"577_CR35","doi-asserted-by":"crossref","first-page":"165","DOI":"10.4111\/icu.2016.57.3.165","volume":"57","author":"JW Kim","year":"2016","unstructured":"Kim, J. W., Moon, Y. T. & Kim, K. D. Nocturia: the circadian voiding disorder. Investig. Clin. Urol. 57, 165\u2013173 (2016).","journal-title":"Investig. Clin. Urol."},{"key":"577_CR36","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/mdc3.12374","volume":"3","author":"A Batla","year":"2016","unstructured":"Batla, A., Phe, V., De Min, L. & Panicker, J. N. Nocturia in Parkinson\u2019s disease: why does it occur and how to manage? Mov. Disord. Clin. Pract. 3, 443\u2013451 (2016).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"577_CR37","first-page":"147ra111","volume":"147","author":"JJ Iliff","year":"2012","unstructured":"Iliff, J. J. et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 147, 147ra111 (2012).","journal-title":"Sci. Transl. Med."},{"key":"577_CR38","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1126\/science.aav2546","volume":"363","author":"JK Holth","year":"2019","unstructured":"Holth, J. K. et al. The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans. Science 363, 880\u2013884 (2019).","journal-title":"Science"},{"key":"577_CR39","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/ene.13135","volume":"24","author":"E Vichayanrat","year":"2017","unstructured":"Vichayanrat, E. et al. Twenty-four-hour ambulatory blood pressure and heart rate profiles in diagnosing orthostatic hypotension in Parkinson\u2019s disease and multiple system atrophy. Eur. J. Neurol. 24, 90\u201397 (2017).","journal-title":"Eur. J. Neurol."},{"key":"577_CR40","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s00415-019-09244-w","volume":"266","author":"F Vallelonga","year":"2019","unstructured":"Vallelonga, F. et al. Blood pressure circadian rhythm alterations in \u03b1-synucleinopathies. J. Neurol. 266, 1141\u20131152 (2019). This investigation revealed different patterns of circadian rhythms of blood pressure in synucleinopathies.","journal-title":"J. Neurol."},{"key":"577_CR41","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0079-6123(08)61581-2","volume":"119","author":"RM Buijs","year":"1998","unstructured":"Buijs, R. M., Hermes, M. H. & Kalsbeek, A. The suprachiasmatic nucleus-paraventricular nucleus interactions: a bridge to the neuroendocrine and autonomic nervous system. Prog. Brain Res. 119, 365\u2013382 (1998).","journal-title":"Prog. Brain Res."},{"key":"577_CR42","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.parkreldis.2016.03.004","volume":"26","author":"M Salsone","year":"2016","unstructured":"Salsone, M. et al. Cardiac sympathetic index identifies patients with Parkinson\u2019s disease and REM behavior disorder. Parkinsonism Relat. Disord. 26, 62\u201366 (2016).","journal-title":"Parkinsonism Relat. Disord."},{"key":"577_CR43","doi-asserted-by":"crossref","DOI":"10.1186\/s12883-020-01722-3","volume":"20","author":"V Arnao","year":"2020","unstructured":"Arnao, V. et al. Impaired circadian heart rate variability in Parkinson\u2019s disease: a time-domain analysis in ambulatory setting. BMC Neurol. 20, 152 (2020).","journal-title":"BMC Neurol."},{"key":"577_CR44","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-021-09502-7","author":"ER Wallace","year":"2021","unstructured":"Wallace, E. R., Segerstrom, S. C., van Horne, C. G., Schmitt, F. A. & Koehl, L. M. Meta-analysis of cognition in Parkinson\u2019s disease mild cognitive impairment and dementia progression. Neuropsychol. Rev. https:\/\/doi.org\/10.1007\/s11065-021-09502-7 (2021).","journal-title":"Neuropsychol. Rev."},{"key":"577_CR45","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/mds.27200","volume":"32","author":"S Sohail","year":"2017","unstructured":"Sohail, S. et al. Sleep fragmentation and Parkinson\u2019s disease pathology in older adults without Parkinson\u2019s disease. Mov. Disord. 32, 1729\u20131737 (2017).","journal-title":"Mov. Disord."},{"key":"577_CR46","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/mdc3.12692","volume":"5","author":"JQ Wu","year":"2018","unstructured":"Wu, J. Q., Li, P., Stavitsky Gilbert, K., Hu, K. & Cronin-Golomb, A. Circadian rest-activity rhythms predict cognitive function in early parkinson\u2019s disease independently of sleep. Mov. Disord. Clin. Pract. 5, 614\u2013619 (2018).","journal-title":"Mov. Disord. Clin. Pract."},{"key":"577_CR47","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S1474-4422(18)30461-7","volume":"18","author":"Y Leng","year":"2019","unstructured":"Leng, Y., Musiek, E. S., Hu, K., Cappuccio, F. P. & Yaffe, K. Association between circadian rhythms and neurodegenerative diseases. Lancet Neurol. 18, 307\u2013318 (2019).","journal-title":"Lancet Neurol."},{"key":"577_CR48","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1001\/jamaneurol.2020.1623","volume":"77","author":"Y Leng","year":"2020","unstructured":"Leng, Y. et al. Association of circadian abnormalities in older adults with an increased risk of developing parkinson disease. JAMA Neurol. 77, 1270\u20131278 (2020).","journal-title":"JAMA Neurol."},{"key":"577_CR49","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/BF02251135","volume":"3","author":"E Fertl","year":"1991","unstructured":"Fertl, E., Auff, E., Doppelbauer, A. & Waldhauser, F. Circadian secretion pattern of melatonin in Parkinson\u2019s disease. J. Neural Transm. Park. Dis. Dement. Sect. 3, 41\u201347 (1991).","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"577_CR50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF02257677","volume":"5","author":"E Fertl","year":"1993","unstructured":"Fertl, E., Auff, E., Doppelbauer, A. & Waldhauser, F. Circadian secretion pattern of melatonin in de novo parkinsonian patients: evidence for phase-shifting properties of l-dopa. J. Neural Transm. Park. Dis. Dement. Sect. 5, 227\u2013234 (1993).","journal-title":"J. Neural Transm. Park. Dis. Dement. Sect."},{"key":"577_CR51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00002826-200303000-00005","volume":"26","author":"R Bordet","year":"2003","unstructured":"Bordet, R. et al. Study of circadian melatonin secretion pattern at different stages of Parkinson\u2019s disease. Clin. Neuropharmacol. 26, 65\u201372 (2003).","journal-title":"Clin. Neuropharmacol."},{"key":"577_CR52","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3389\/fnins.2020.00505","volume":"14","author":"L Li","year":"2020","unstructured":"Li, L. et al. Elevated plasma melatonin levels are correlated with the non-motor symptoms in parkinson\u2019s disease: a cross-sectional study. Front. Neurosci. 14, 505 (2020).","journal-title":"Front. Neurosci."},{"key":"577_CR53","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.sleep.2013.10.016","volume":"15","author":"SJ Bolitho","year":"2014","unstructured":"Bolitho, S. J. et al. Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease. Sleep Med. 15, 342\u2013347 (2014).","journal-title":"Sleep Med."},{"key":"577_CR54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.sleep.2020.07.043","volume":"75","author":"H Kataoka","year":"2020","unstructured":"Kataoka, H., Saeki, K., Kurumatani, N., Sugie, K. & Obayashi, K. Melatonin secretion in patients with Parkinson\u2019s disease receiving different-dose levodopa therapy. Sleep Med. 75, 309\u2013314 (2020).","journal-title":"Sleep Med."},{"key":"577_CR55","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/cxo.12824","volume":"102","author":"LA Ostrin","year":"2019","unstructured":"Ostrin, L. A. Ocular and systemic melatonin and the influence of light exposure. Clin. Exp. Optom. 102, 99\u2013108 (2019).","journal-title":"Clin. Exp. Optom."},{"key":"577_CR56","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0197-4580(97)80309-0","volume":"18","author":"A Hartmann","year":"1997","unstructured":"Hartmann, A., Veldhuis, J. D., Deuschle, M., Standhardt, H. & Heuser, I. Twenty-four hour cortisol release profiles in patients with Alzheimer\u2019s and Parkinson\u2019s disease compared to normal controls: ultradian secretory pulsatility and diurnal variation. Neurobiol. Aging 18, 285\u2013289 (1997).","journal-title":"Neurobiol. Aging"},{"key":"577_CR57","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cger.2019.09.012","volume":"36","author":"S Ray","year":"2020","unstructured":"Ray, S. & Agarwal, P. Depression and anxiety in Parkinson disease. Clin. Geriatr. Med. 36, 93\u2013104 (2020).","journal-title":"Clin. Geriatr. Med."},{"key":"577_CR58","doi-asserted-by":"crossref","first-page":"112186","DOI":"10.1016\/j.bbr.2019.112186","volume":"376","author":"J Mendoza","year":"2019","unstructured":"Mendoza, J. Circadian insights into the biology of depression: symptoms, treatments and animal models. Behav. Brain Res. 376, 112186 (2019).","journal-title":"Behav. Brain Res."},{"key":"577_CR59","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1002\/mds.1039","volume":"16","author":"G Pierangeli","year":"2001","unstructured":"Pierangeli, G. et al. Nocturnal body core temperature falls in Parkinson\u2019s disease but not in multiple-system atrophy. Mov. Disord. 16, 226\u2013232 (2001).","journal-title":"Mov. Disord."},{"key":"577_CR60","volume":"8","author":"G Zhong","year":"2013","unstructured":"Zhong, G., Bolitho, S., Grunstein, R., Naismith, S. L. & Lewis, S. J. The relationship between thermoregulation and REM sleep behaviour disorder in Parkinson\u2019s disease. PLoS One 8, e72661 (2013).","journal-title":"PLoS One"},{"key":"577_CR61","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1159\/000119735","volume":"56","author":"K Suzuki","year":"2007","unstructured":"Suzuki, K. et al. Circadian variation of core body temperature in Parkinson disease patients with depression: a potential biological marker for depression in Parkinson disease. Neuropsychobiology 56, 172\u2013179 (2007).","journal-title":"Neuropsychobiology"},{"key":"577_CR62","doi-asserted-by":"crossref","DOI":"10.1111\/jsr.12939","volume":"29","author":"AK Raupach","year":"2020","unstructured":"Raupach, A. K. et al. Assessing the role of nocturnal core body temperature dysregulation as a biomarker of neurodegeneration. J. Sleep Res. 29, e12939 (2020).","journal-title":"J. Sleep Res."},{"key":"577_CR63","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1468-1331.2009.02848.x","volume":"17","author":"Y Cai","year":"2010","unstructured":"Cai, Y., Liu, S., Sothern, R. B., Xu, S. & Chan, P. Expression of clock genes Per1 and Bmal1 in total leukocytes in health and Parkinson\u2019s disease. Eur. J. Neurol. 17, 550\u2013554 (2010).","journal-title":"Eur. J. Neurol."},{"key":"577_CR64","volume":"5","author":"Z Gu","year":"2015","unstructured":"Gu, Z. et al. Association of ARNTL and PER1 genes with Parkinson\u2019s disease: a case-control study of Han Chinese. Sci. Rep. 5, 15891 (2015).","journal-title":"Sci. Rep."},{"key":"577_CR65","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/nrneurol.2017.157","volume":"14","author":"B Hogl","year":"2018","unstructured":"Hogl, B., Stefani, A. & Videnovic, A. Idiopathic REM sleep behaviour disorder and neurodegeneration \u2014 an update. Nat. Rev. Neurol. 14, 40\u201355 (2018). A comprehensive review of RBD and its association with neurodegenerative disorders.","journal-title":"Nat. Rev. Neurol."},{"key":"577_CR66","unstructured":"Feriante, J. & Araujo, J. F. Physiology, REM Sleep (StatPearls Publishing, 2021)."},{"key":"577_CR67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.sleep.2018.07.019","volume":"52","author":"K Weissova","year":"2018","unstructured":"Weissova, K. et al. Circadian rhythms of melatonin and peripheral clock gene expression in idiopathic REM sleep behavior disorder. Sleep Med. 52, 1\u20136 (2018).","journal-title":"Sleep Med."},{"key":"577_CR68","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/0024-3205(84)90519-8","volume":"35","author":"JC Stoof","year":"1984","unstructured":"Stoof, J. C. & Kebabian, J. W. Two dopamine receptors: biochemistry, physiology and pharmacology. Life Sci. 35, 2281\u20132296 (1984).","journal-title":"Life Sci."},{"key":"577_CR69","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrneurol.2014.206","volume":"10","author":"A Videnovic","year":"2014","unstructured":"Videnovic, A., Lazar, A. S., Barker, R. A. & Overeem, S. \u2018The clocks that time us\u2019 \u2014 circadian rhythms in neurodegenerative disorders. Nat. Rev. Neurol. 10, 683\u2013693 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"577_CR70","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12868-019-0506-8","volume":"20","author":"B Doktor","year":"2019","unstructured":"Doktor, B., Damulewicz, M. & Pyza, E. Effects of MUL1 and PARKIN on the circadian clock, brain and behaviour in Drosophila Parkinson\u2019s disease models. BMC Neurosci. 20, 24 (2019).","journal-title":"BMC Neurosci."},{"key":"577_CR71","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2017.04.014","volume":"104","author":"H Julienne","year":"2017","unstructured":"Julienne, H., Buhl, E., Leslie, D. S. & Hodge, J. J. L. Drosophila PINK1 and parkin loss-of-function mutants display a range of non-motor Parkinson\u2019s disease phenotypes. Neurobiol. Dis. 104, 15\u201323 (2017).","journal-title":"Neurobiol. Dis."},{"key":"577_CR72","doi-asserted-by":"crossref","first-page":"6570","DOI":"10.1096\/fj.201901565RR","volume":"34","author":"WW Liu","year":"2020","unstructured":"Liu, W. W. et al. BMAL1 regulation of microglia-mediated neuroinflammation in MPTP-induced Parkinson\u2019s disease mouse model. FASEB J. 34, 6570\u20136581 (2020).","journal-title":"FASEB J."},{"key":"577_CR73","doi-asserted-by":"crossref","first-page":"4854732","DOI":"10.1155\/2018\/4854732","volume":"2018","author":"Y Wang","year":"2018","unstructured":"Wang, Y. et al. Disruption of the circadian clock alters antioxidative defense via the SIRT1-BMAL1 pathway in 6-OHDA-induced models of Parkinson\u2019s disease. Oxid. Med. Cell Longev. 2018, 4854732 (2018).","journal-title":"Oxid. Med. Cell Longev."},{"key":"577_CR74","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/mp.2016.47","volume":"22","author":"E Lauretti","year":"2017","unstructured":"Lauretti, E., Di Meco, A., Merali, S. & Pratico, D. Circadian rhythm dysfunction: a novel environmental risk factor for Parkinson\u2019s disease. Mol. Psychiatry 22, 280\u2013286 (2017). This investigation reported the modulation of neuropathological changes within substantia nigra that pre-existed circadian dysregulation in animal models of PD.","journal-title":"Mol. Psychiatry"},{"key":"577_CR75","first-page":"742","volume":"41","author":"J Kim","year":"2018","unstructured":"Kim, J. et al. Abrogation of the circadian nuclear receptor REV-ERB\u03b1 exacerbates 6-hydroxydopamine-induced dopaminergic neurodegeneration. Mol. Cell 41, 742\u2013752 (2018).","journal-title":"Mol. Cell"},{"key":"577_CR76","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-10304-9","author":"L Huang","year":"2020","unstructured":"Huang, L., Zhang, D., Ji, J., Wang, Y. & Zhang, R. Central retina changes in Parkinson\u2019s disease: a systematic review and meta-analysis. J. Neurol. https:\/\/doi.org\/10.1007\/s00415-020-10304-9 (2020).","journal-title":"J. Neurol."},{"key":"577_CR77","doi-asserted-by":"crossref","first-page":"16003","DOI":"10.1038\/npjamd.2016.3","volume":"2","author":"JB Lin","year":"2016","unstructured":"Lin, J. B., Tsubota, K. & Apte, R. S. A glimpse at the aging eye. NPJ Aging Mech. Dis. 2, 16003 (2016).","journal-title":"NPJ Aging Mech. Dis."},{"key":"577_CR78","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.pneurobio.2019.01.002","volume":"174","author":"K Fifel","year":"2019","unstructured":"Fifel, K. & Videnovic, A. Chronotherapies for Parkinson\u2019s disease. Prog. Neurobiol. 174, 16\u201327 (2019). A review of circadian-based interventions for PD.","journal-title":"Prog. Neurobiol."},{"key":"577_CR79","first-page":"199","volume":"23","author":"GL Willis","year":"2012","unstructured":"Willis, G. L., Moore, C. & Armstrong, S. M. A historical justification for and retrospective analysis of the systematic application of light therapy in Parkinson\u2019s disease. Rev. Neurosci. 23, 199\u2013226 (2012).","journal-title":"Rev. Neurosci."},{"key":"577_CR80","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/07420520701420717","volume":"24","author":"GL Willis","year":"2007","unstructured":"Willis, G. L. & Turner, E. J. Primary and secondary features of Parkinson\u2019s disease improve with strategic exposure to bright light: a case series study. Chronobiol. Int. 24, 521\u2013537 (2007).","journal-title":"Chronobiol. Int."},{"key":"577_CR81","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sleep.2018.01.001","volume":"44","author":"JK Martino","year":"2018","unstructured":"Martino, J. K., Freelance, C. B. & Willis, G. L. The effect of light exposure on insomnia and nocturnal movement in Parkinson\u2019s disease: an open label, retrospective, longitudinal study. Sleep. Med. 44, 24\u201331 (2018).","journal-title":"Sleep. Med."},{"key":"577_CR82","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/mds.21542","volume":"22","author":"S Paus","year":"2007","unstructured":"Paus, S. et al. Bright light therapy in Parkinson\u2019s disease: a pilot study. Mov. Disord. 22, 1495\u20131498 (2007).","journal-title":"Mov. Disord."},{"key":"577_CR83","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1001\/jamaneurol.2016.5192","volume":"74","author":"A Videnovic","year":"2017","unstructured":"Videnovic, A. et al. Timed light therapy for sleep and daytime sleepiness associated with parkinson disease: a randomized clinical trial. JAMA Neurol. 74, 411\u2013418 (2017).","journal-title":"JAMA Neurol."},{"key":"577_CR84","doi-asserted-by":"crossref","first-page":"e1145","DOI":"10.1212\/WNL.0000000000007090","volume":"92","author":"S Rutten","year":"2019","unstructured":"Rutten, S. et al. Bright light therapy for depression in Parkinson disease: a randomized controlled trial. Neurology 92, e1145\u2013e1156 (2019).","journal-title":"Neurology"},{"key":"577_CR85","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.parkreldis.2013.03.003","volume":"19","author":"S Rios Romenets","year":"2013","unstructured":"Rios Romenets, S. et al. Doxepin and cognitive behavioural therapy for insomnia in patients with Parkinson\u2019s disease \u2014 a randomized study. Parkinsonism Relat. Disord. 19, 670\u2013675 (2013).","journal-title":"Parkinsonism Relat. Disord."},{"key":"577_CR86","doi-asserted-by":"crossref","first-page":"117345","DOI":"10.1016\/j.lfs.2020.117345","volume":"245","author":"YS Feng","year":"2020","unstructured":"Feng, Y. S. et al. The benefits and mechanisms of exercise training for Parkinson\u2019s disease. Life Sci. 245, 117345 (2020).","journal-title":"Life Sci."},{"key":"577_CR87","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1002\/mds.28009","volume":"35","author":"AW Amara","year":"2020","unstructured":"Amara, A. W. et al. Randomized, controlled trial of exercise on objective and subjective sleep in Parkinson\u2019s disease. Mov. Disord. 35, 947\u2013958 (2020).","journal-title":"Mov. Disord."},{"key":"577_CR88","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1111\/bph.14116","volume":"175","author":"N Zisapel","year":"2018","unstructured":"Zisapel, N. New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation. Br. J. Pharmacol. 175, 3190\u20133199 (2018).","journal-title":"Br. J. Pharmacol."},{"key":"577_CR89","doi-asserted-by":"crossref","first-page":"110485","DOI":"10.1016\/j.biopha.2020.110485","volume":"129","author":"DL Delgado-Lara","year":"2020","unstructured":"Delgado-Lara, D. L. et al. Effect of melatonin administration on the PER1 and BMAL1 clock genes in patients with Parkinson\u2019s disease. Biomed. Pharmacother. 129, 110485 (2020).","journal-title":"Biomed. Pharmacother."},{"key":"577_CR90","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s11940-017-0461-6","volume":"19","author":"AW Amara","year":"2017","unstructured":"Amara, A. W., Chahine, L. M. & Videnovic, A. Treatment of sleep dysfunction in Parkinson\u2019s disease. Curr. Treat. Options Neurol. 19, 26 (2017).","journal-title":"Curr. Treat. Options Neurol."},{"key":"577_CR91","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.sleep.2005.04.004","volume":"6","author":"GA Dowling","year":"2005","unstructured":"Dowling, G. A. et al. Melatonin for sleep disturbances in Parkinson\u2019s disease. Sleep. Med. 6, 459\u2013466 (2005).","journal-title":"Sleep. Med."},{"key":"577_CR92","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S1474-4422(10)70287-8","volume":"9","author":"PJ Morrison","year":"2010","unstructured":"Morrison, P. J. Accurate prevalence and uptake of testing for Huntington\u2019s disease. Lancet Neurol. 9, 1147 (2010).","journal-title":"Lancet Neurol."},{"key":"577_CR93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/BF00194305","volume":"89","author":"PS Harper","year":"1992","unstructured":"Harper, P. S. The epidemiology of Huntington\u2019s disease. Hum. Genet. 89, 365\u2013376 (1992).","journal-title":"Hum. Genet."},{"key":"577_CR94","doi-asserted-by":"crossref","first-page":"15005","DOI":"10.1038\/nrdp.2015.5","volume":"1","author":"GP Bates","year":"2015","unstructured":"Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Prim. 1, 15005 (2015).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"577_CR95","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/mds.25075","volume":"27","author":"T Pringsheim","year":"2012","unstructured":"Pringsheim, T. et al. The incidence and prevalence of Huntington\u2019s disease: a systematic review and meta-analysis. Mov. Disord. 27, 1083\u20131091 (2012).","journal-title":"Mov. Disord."},{"key":"577_CR96","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/306234a0","volume":"306","author":"JF Gusella","year":"1983","unstructured":"Gusella, J. F. et al. A polymorphic DNA marker genetically linked to Huntington\u2019s disease. Nature 306, 234\u2013238 (1983).","journal-title":"Nature"},{"key":"577_CR97","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.2890209","volume":"238","author":"TC Gilliam","year":"1987","unstructured":"Gilliam, T. C. et al. A DNA segment encoding two genes very tightly linked to Huntington\u2019s disease. Science 238, 950\u2013952 (1987).","journal-title":"Science"},{"key":"577_CR98","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","author":"No Authors Listed.","year":"1993","unstructured":"No Authors Listed. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington\u2019s disease chromosomes. The Huntington\u2019s Disease Collaborative Research Group. Cell 72, 971\u2013983 (1993).","journal-title":"Cell"},{"key":"577_CR99","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1212\/WNL.45.10.1867","volume":"45","author":"KA Bamford","year":"1995","unstructured":"Bamford, K. A., Caine, E. D., Kido, D. K., Cox, C. & Shoulson, I. A prospective evaluation of cognitive decline in early Huntington\u2019s disease: functional and radiographic correlates. Neurology 45, 1867\u20131873 (1995).","journal-title":"Neurology"},{"key":"577_CR100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/jnnp.71.3.310","volume":"71","author":"JS Paulsen","year":"2001","unstructured":"Paulsen, J. S., Ready, R. E., Hamilton, J. M., Mega, M. S. & Cummings, J. L. Neuropsychiatric aspects of Huntington\u2019s disease. J. Neurol. Neurosurg. Psychiatry 71, 310\u2013314 (2001).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"577_CR101","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s11910-010-0163-x","volume":"11","author":"AO Goodman","year":"2011","unstructured":"Goodman, A. O. et al. Asymptomatic sleep abnormalities are a common early feature in patients with Huntington\u2019s disease. Curr. Neurol. Neurosci. Rep. 11, 211\u2013217 (2011).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"577_CR102","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1212\/WNL.35.11.1672","volume":"35","author":"P Hansotia","year":"1985","unstructured":"Hansotia, P., Wall, R. & Berendes, J. Sleep disturbances and severity of Huntington\u2019s disease. Neurology 35, 1672\u20131674 (1985).","journal-title":"Neurology"},{"key":"577_CR103","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF00314313","volume":"235","author":"W Emser","year":"1988","unstructured":"Emser, W., Brenner, M., Stober, T. & Schimrigk, K. Changes in nocturnal sleep in Huntington\u2019s and Parkinson\u2019s disease. J. Neurol. 235, 177\u2013179 (1988).","journal-title":"J. Neurol."},{"key":"577_CR104","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/0987-7053(96)81034-3","volume":"25","author":"R Silvestri","year":"1995","unstructured":"Silvestri, R. et al. Sleep features in Tourette\u2019s syndrome, neuroacanthocytosis and Huntington\u2019s chorea. Neurophysiol. Clin. 25, 66\u201377 (1995).","journal-title":"Neurophysiol. Clin."},{"key":"577_CR105","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1080\/15402000903190215","volume":"7","author":"M Cuturic","year":"2009","unstructured":"Cuturic, M., Abramson, R. K., Vallini, D., Frank, E. M. & Shamsnia, M. Sleep patterns in patients with Huntington\u2019s disease and their unaffected first-degree relatives: a brief report. Behav. Sleep Med. 7, 245\u2013254 (2009).","journal-title":"Behav. Sleep Med."},{"key":"577_CR106","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1001\/archneur.65.4.482","volume":"65","author":"I Arnulf","year":"2008","unstructured":"Arnulf, I. et al. Rapid eye movement sleep disturbances in Huntington disease. Arch. Neurol. 65, 482\u2013488 (2008).","journal-title":"Arch. Neurol."},{"key":"577_CR107","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1523\/JNEUROSCI.3842-04.2005","volume":"25","author":"AJ Morton","year":"2005","unstructured":"Morton, A. J. et al. Disintegration of the sleep-wake cycle and circadian timing in Huntington\u2019s disease. J. Neurosci. 25, 157\u2013163 (2005). This study revealed disruption of circadian rhythms throughout the course of HD, in animal models and individuals affected by the disease.","journal-title":"J. Neurosci."},{"key":"577_CR108","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.expneurol.2010.12.011","volume":"228","author":"T Kudo","year":"2011","unstructured":"Kudo, T. et al. Dysfunctions in circadian behavior and physiology in mouse models of Huntington\u2019s disease. Exp. Neurol. 228, 80\u201390 (2011). This study revealed reduced rhythms of spontaneous neuronal activity and clock gene expression within the suprachiasmatic nucleus in several animal models of HD.","journal-title":"Exp. Neurol."},{"key":"577_CR109","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fpsyt.2019.00221","volume":"10","author":"R Herzog-Krzywoszanska","year":"2019","unstructured":"Herzog-Krzywoszanska, R. & Krzywoszanski, L. Sleep disorders in Huntington\u2019s disease. Front. Psychiatry 10, 221 (2019).","journal-title":"Front. Psychiatry"},{"key":"577_CR110","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1192\/bjp.171.4.393c","volume":"171","author":"N Taylor","year":"1997","unstructured":"Taylor, N. & Bramble, D. Sleep disturbance and Huntingdon\u2019s disease. Br. J. Psychiatry 171, 393 (1997).","journal-title":"Br. J. Psychiatry"},{"key":"577_CR111","doi-asserted-by":"crossref","first-page":"RRN1189","DOI":"10.1371\/currents.RRN1189","volume":"2","author":"AO Goodman","year":"2010","unstructured":"Goodman, A. O., Morton, A. J. & Barker, R. A. Identifying sleep disturbances in Huntington\u2019s disease using a simple disease-focused questionnaire. PLoS Curr. 2, RRN1189 (2010).","journal-title":"PLoS Curr."},{"key":"577_CR112","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.parkreldis.2010.02.009","volume":"16","author":"NA Aziz","year":"2010","unstructured":"Aziz, N. A., Anguelova, G. V., Marinus, J., Lammers, G. J. & Roos, R. A. Sleep and circadian rhythm alterations correlate with depression and cognitive impairment in Huntington\u2019s disease. Parkinsonism Relat. Disord. 16, 345\u2013350 (2010).","journal-title":"Parkinsonism Relat. Disord."},{"key":"577_CR113","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3233\/JHD-180291","volume":"7","author":"EB Diago","year":"2018","unstructured":"Diago, E. B. et al. Circadian rhythm, cognition, and mood disorders in Huntington\u2019s disease. J. Huntingt. Dis. 7, 193\u2013198 (2018).","journal-title":"J. Huntingt. Dis."},{"key":"577_CR114","doi-asserted-by":"crossref","first-page":"407","DOI":"10.2217\/nmt.11.45","volume":"1","author":"EA Epping","year":"2011","unstructured":"Epping, E. A. & Paulsen, J. S. Depression in the early stages of Huntington disease. Neurodegener. Dis. Manag. 1, 407\u2013414 (2011).","journal-title":"Neurodegener. Dis. Manag."},{"key":"577_CR115","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3390\/brainsci7060067","volume":"7","author":"RA Paoli","year":"2017","unstructured":"Paoli, R. A. et al. Neuropsychiatric burden in huntington\u2019s disease. Brain Sci. 7, 67 (2017).","journal-title":"Brain Sci."},{"key":"577_CR116","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/mds.26926","volume":"32","author":"M Saenz-Farret","year":"2017","unstructured":"Saenz-Farret, M. et al. Neuropsychiatric symptoms and premanifest Huntington\u2019s disease. Mov. Disord. 32, 481 (2017).","journal-title":"Mov. Disord."},{"key":"577_CR117","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/BF00314781","volume":"238","author":"M Wiegand","year":"1991","unstructured":"Wiegand, M. et al. Nocturnal sleep in Huntington\u2019s disease. J. Neurol. 238, 203\u2013220 (1991).","journal-title":"J. Neurol."},{"key":"577_CR118","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1002\/mds.870110406","volume":"11","author":"JP van Vugt","year":"1996","unstructured":"van Vugt, J. P., van Hilten, B. J. & Roos, R. A. Hypokinesia in Huntington\u2019s disease. Mov. Disord. 11, 384\u2013388 (1996).","journal-title":"Mov. Disord."},{"key":"577_CR119","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/mds.1097","volume":"16","author":"JP van Vugt","year":"2001","unstructured":"van Vugt, J. P. et al. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington\u2019s disease. Mov. Disord. 16, 481\u2013488 (2001).","journal-title":"Mov. Disord."},{"key":"577_CR120","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1007\/s00415-005-0709-z","volume":"252","author":"CB Hurelbrink","year":"2005","unstructured":"Hurelbrink, C. B., Lewis, S. J. & Barker, R. A. The use of the Actiwatch-Neurologica system to objectively assess the involuntary movements and sleep-wake activity in patients with mild-moderate Huntington\u2019s disease. J. Neurol. 252, 642\u2013647 (2005).","journal-title":"J. Neurol."},{"key":"577_CR121","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jneumeth.2016.01.009","volume":"265","author":"J Townhill","year":"2016","unstructured":"Townhill, J. et al. Using Actiwatch to monitor circadian rhythm disturbance in Huntington\u2019 disease: a cautionary note. J. Neurosci. Methods 265, 13\u201318 (2016).","journal-title":"J. Neurosci. Methods"},{"key":"577_CR122","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1007\/s00415-009-5196-1","volume":"256","author":"NA Aziz","year":"2009","unstructured":"Aziz, N. A. et al. Delayed onset of the diurnal melatonin rise in patients with Huntington\u2019s disease. J. Neurol. 256, 1961\u20131965 (2009).","journal-title":"J. Neurol."},{"key":"577_CR123","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/mds.26003","volume":"29","author":"E Kalliolia","year":"2014","unstructured":"Kalliolia, E. et al. Plasma melatonin is reduced in Huntington\u2019s disease. Mov. Disord. 29, 1511\u20131515 (2014).","journal-title":"Mov. Disord."},{"key":"577_CR124","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1016\/j.psyneuen.2012.10.020","volume":"38","author":"CA Shirbin","year":"2013","unstructured":"Shirbin, C. A. et al. Cortisol and depression in pre-diagnosed and early stage Huntington\u2019s disease. Psychoneuroendocrinology 38, 2439\u20132447 (2013).","journal-title":"Psychoneuroendocrinology"},{"key":"577_CR125","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/0006-3223(91)90007-9","volume":"30","author":"IJ Heuser","year":"1991","unstructured":"Heuser, I. J., Chase, T. N. & Mouradian, M. M. The limbic-hypothalamic-pituitary-adrenal axis in Huntington\u2019s disease. Biol. Psychiatry 30, 943\u2013952 (1991).","journal-title":"Biol. Psychiatry"},{"key":"577_CR126","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0004962","volume":"4","author":"N Saleh","year":"2009","unstructured":"Saleh, N. et al. Neuroendocrine disturbances in Huntington\u2019s disease. PLoS One 4, e4962 (2009).","journal-title":"PLoS One"},{"key":"577_CR127","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/jc.2008-2543","volume":"94","author":"NA Aziz","year":"2009","unstructured":"Aziz, N. A. et al. Increased hypothalamic-pituitary-adrenal axis activity in Huntington\u2019s disease. J. Clin. Endocrinol. Metab. 94, 1223\u20131228 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"577_CR128","first-page":"539","volume":"68","author":"A Adamczak-Ratajczak","year":"2017","unstructured":"Adamczak-Ratajczak, A. et al. Circadian rhythms of melatonin and cortisol in manifest Huntington\u2019s disease and in acute cortical ischemic stroke. J. Physiol. Pharmacol. 68, 539\u2013546 (2017).","journal-title":"J. Physiol. Pharmacol."},{"key":"577_CR129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0006-8993(92)90927-2","volume":"580","author":"A Kalsbeek","year":"1992","unstructured":"Kalsbeek, A., Buijs, R. M., van Heerikhuize, J. J., Arts, M. & van der Woude, T. P. Vasopressin-containing neurons of the suprachiasmatic nuclei inhibit corticosterone release. Brain Res. 580, 62\u201367 (1992).","journal-title":"Brain Res."},{"key":"577_CR130","first-page":"117","volume":"36","author":"DJ van Wamelen","year":"2013","unstructured":"van Wamelen, D. J. et al. Suprachiasmatic nucleus neuropeptide expression in patients with Huntington\u2019s Disease. Sleep 36, 117\u2013125 (2013).","journal-title":"Sleep"},{"key":"577_CR131","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbscr.2018.07.001","volume":"6","author":"DM Bartlett","year":"2019","unstructured":"Bartlett, D. M. et al. Investigating the relationships between hypothalamic volume and measures of circadian rhythm and habitual sleep in premanifest Huntington\u2019s disease. Neurobiol. Sleep Circadian Rhythms 6, 1\u20138 (2019).","journal-title":"Neurobiol. Sleep Circadian Rhythms"},{"key":"577_CR132","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/nrn3570","volume":"14","author":"MA Pouladi","year":"2013","unstructured":"Pouladi, M. A., Morton, A. J. & Hayden, M. R. Choosing an animal model for the study of Huntington\u2019s disease. Nat. Rev. Neurosci. 14, 708\u2013721 (2013).","journal-title":"Nat. Rev. Neurosci."},{"key":"577_CR133","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3233\/JHD-180325","volume":"8","author":"L Rieke","year":"2019","unstructured":"Rieke, L. et al. Activity behaviour of minipigs transgenic for the Huntington gene. J. Huntingt. Dis. 8, 23\u201331 (2019).","journal-title":"J. Huntingt. Dis."},{"key":"577_CR134","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/brain\/awt128","volume":"136","author":"S Kantor","year":"2013","unstructured":"Kantor, S., Szabo, L., Varga, J., Cuesta, M. & Morton, A. J. Progressive sleep and electroencephalogram changes in mice carrying the Huntington\u2019s disease mutation. Brain 136, 2147\u20132158 (2013).","journal-title":"Brain"},{"key":"577_CR135","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/brain\/awt132","volume":"136","author":"SP Fisher","year":"2013","unstructured":"Fisher, S. P. et al. Longitudinal analysis of the electroencephalogram and sleep phenotype in the R6\/2 mouse model of Huntington\u2019s disease. Brain 136, 2159\u20132172 (2013).","journal-title":"Brain"},{"key":"577_CR136","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1385\/JMN\/31:02:139","volume":"31","author":"J Fahrenkrug","year":"2007","unstructured":"Fahrenkrug, J., Popovic, N., Georg, B., Brundin, P. & Hannibal, J. Decreased VIP and VPAC2 receptor expression in the biological clock of the R6\/2 Huntington\u2019s disease mouse. J. Mol. Neurosci. 31, 139\u2013148 (2007).","journal-title":"J. Mol. Neurosci."},{"key":"577_CR137","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.bbr.2009.04.034","volume":"203","author":"O Rudenko","year":"2009","unstructured":"Rudenko, O., Tkach, V., Berezin, V. & Bock, E. Detection of early behavioral markers of Huntington\u2019s disease in R6\/2 mice employing an automated social home cage. Behav. Brain Res. 203, 188\u2013199 (2009).","journal-title":"Behav. Brain Res."},{"key":"577_CR138","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.bbr.2009.06.031","volume":"205","author":"FJ Bode","year":"2009","unstructured":"Bode, F. J. et al. Increased numbers of motor activity peaks during light cycle are associated with reductions in adrenergic alpha(2)-receptor levels in a transgenic Huntington\u2019s disease rat model. Behav. Brain Res. 205, 175\u2013182 (2009).","journal-title":"Behav. Brain Res."},{"key":"577_CR139","volume":"6","author":"S Pietropaolo","year":"2011","unstructured":"Pietropaolo, S., Delage, P., Cayzac, S., Crusio, W. E. & Cho, Y. H. Sex-dependent changes in social behaviors in motor pre-symptomatic R6\/1 mice. PLoS One 6, e19965 (2011).","journal-title":"PLoS One"},{"key":"577_CR140","volume":"8","author":"DH Loh","year":"2013","unstructured":"Loh, D. H., Kudo, T., Truong, D., Wu, Y. & Colwell, C. S. The Q175 mouse model of Huntington\u2019s disease shows gene dosage- and age-related decline in circadian rhythms of activity and sleep. PLoS One 8, e69993 (2013).","journal-title":"PLoS One"},{"key":"577_CR141","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.1093\/hmg\/ddu047","volume":"23","author":"AJ Morton","year":"2014","unstructured":"Morton, A. J. et al. Early and progressive circadian abnormalities in Huntington\u2019s disease sheep are unmasked by social environment. Hum. Mol. Genet. 23, 3375\u20133383 (2014).","journal-title":"Hum. Mol. Genet."},{"key":"577_CR142","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.expneurol.2016.06.028","volume":"283","author":"BD Dufour","year":"2016","unstructured":"Dufour, B. D. & McBride, J. L. Corticosterone dysregulation exacerbates disease progression in the R6\/2 transgenic mouse model of Huntington\u2019s disease. Exp. Neurol. 283, 308\u2013317 (2016).","journal-title":"Exp. Neurol."},{"key":"577_CR143","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12624","volume":"68","author":"AJ Morton","year":"2020","unstructured":"Morton, A. J. et al. Increased plasma melatonin in presymptomatic Huntington disease sheep (Ovis aries): Compensatory neuroprotection in a neurodegenerative disease? J. Pineal Res. 68, e12624 (2020).","journal-title":"J. Pineal Res."},{"key":"577_CR144","volume":"15","author":"F Xu","year":"2019","unstructured":"Xu, F., Kula-Eversole, E., Iwanaszko, M., Lim, C. & Allada, R. Ataxin2 functions via CrebA to mediate Huntingtin toxicity in circadian clock neurons. PLoS Genet. 15, e1008356 (2019).","journal-title":"PLoS Genet."},{"key":"577_CR145","doi-asserted-by":"crossref","first-page":"7174","DOI":"10.1038\/s41598-019-43612-w","volume":"9","author":"A Farago","year":"2019","unstructured":"Farago, A., Zsindely, N. & Bodai, L. Mutant huntingtin disturbs circadian clock gene expression and sleep patterns in Drosophila. Sci. Rep. 9, 7174 (2019).","journal-title":"Sci. Rep."},{"key":"577_CR146","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.celrep.2019.03.015","volume":"27","author":"F Xu","year":"2019","unstructured":"Xu, F. et al. Circadian clocks function in concert with heat shock organizing protein to modulate mutant huntingtin aggregation and toxicity. Cell Rep. 27, 59\u201370 (2019).","journal-title":"Cell Rep."},{"key":"577_CR147","volume":"7","author":"A Neueder","year":"2017","unstructured":"Neueder, A. et al. HSF1-dependent and -independent regulation of the mammalian in vivo heat shock response and its impairment in Huntington\u2019s disease mouse models. Sci. Rep. 7, 12556 (2017).","journal-title":"Sci. Rep."},{"key":"577_CR148","doi-asserted-by":"crossref","first-page":"7869","DOI":"10.1523\/JNEUROSCI.0649-07.2007","volume":"27","author":"PN Pallier","year":"2007","unstructured":"Pallier, P. N. et al. Pharmacological imposition of sleep slows cognitive decline and reverses dysregulation of circadian gene expression in a transgenic mouse model of Huntington\u2019s disease. J. Neurosci. 27, 7869\u20137878 (2007).","journal-title":"J. Neurosci."},{"key":"577_CR149","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1002\/jnr.24320","volume":"96","author":"D Kuljis","year":"2018","unstructured":"Kuljis, D., Kudo, T., Tahara, Y., Ghiani, C. A. & Colwell, C. S. Pathophysiology in the suprachiasmatic nucleus in mouse models of Huntington\u2019s disease. J. Neurosci. Res. 96, 1862\u20131875 (2018).","journal-title":"J. Neurosci. Res."},{"key":"577_CR150","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0088-19.2019","author":"K Ouk","year":"2019","unstructured":"Ouk, K., Aungier, J., Ware, M. & Morton, A. J. Abnormal photic entrainment to phase-delaying stimuli in the R6\/2 mouse model of Huntington\u2019s disease, despite retinal responsiveness to light. eNeuro https:\/\/doi.org\/10.1523\/ENEURO.0088-19.2019 (2019).","journal-title":"eNeuro"},{"key":"577_CR151","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1523\/JNEUROSCI.0571-18.2018","volume":"39","author":"MS Lin","year":"2019","unstructured":"Lin, M. S. et al. Degeneration of ipRGCs in mouse models of huntington\u2019s disease disrupts non-image-forming behaviors before motor impairment. J. Neurosci. 39, 1505\u20131524 (2019).","journal-title":"J. Neurosci."},{"key":"577_CR152","first-page":"5418","volume":"25","author":"K Ouk","year":"2016","unstructured":"Ouk, K., Hughes, S., Pothecary, C. A., Peirson, S. N. & Morton, A. J. Attenuated pupillary light responses and downregulation of opsin expression parallel decline in circadian disruption in two different mouse models of Huntington\u2019s disease. Hum. Mol. Genet. 25, 5418\u20135432 (2016).","journal-title":"Hum. Mol. Genet."},{"key":"577_CR153","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.expneurol.2016.09.007","volume":"286","author":"K Ouk","year":"2016","unstructured":"Ouk, K., Aungier, J. & Morton, A. J. Progressive gene dose-dependent disruption of the methamphetamine-sensitive circadian oscillator-driven rhythms in a knock-in mouse model of Huntington\u2019s disease. Exp. Neurol. 286, 69\u201382 (2016).","journal-title":"Exp. Neurol."},{"key":"577_CR154","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.neuropharm.2017.12.033","volume":"131","author":"K Ouk","year":"2018","unstructured":"Ouk, K., Aungier, J., Cuesta, M. & Morton, A. J. Chronic paroxetine treatment prevents disruption of methamphetamine-sensitive circadian oscillator in a transgenic mouse model of Huntington\u2019s disease. Neuropharmacology 131, 337\u2013350 (2018).","journal-title":"Neuropharmacology"},{"key":"577_CR155","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.brainres.2009.03.072","volume":"1279","author":"PN Pallier","year":"2009","unstructured":"Pallier, P. N. & Morton, A. J. Management of sleep\/wake cycles improves cognitive function in a transgenic mouse model of Huntington\u2019s disease. Brain Res. 1279, 90\u201398 (2009).","journal-title":"Brain Res."},{"key":"577_CR156","volume":"5","author":"NI Wood","year":"2010","unstructured":"Wood, N. I. et al. Responses to environmental enrichment differ with sex and genotype in a transgenic mouse model of Huntington\u2019s disease. PLoS One 5, e9077 (2010).","journal-title":"PLoS One"},{"key":"577_CR157","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147583","volume":"11","author":"DA Kuljis","year":"2016","unstructured":"Kuljis, D. A. et al. Sex differences in circadian dysfunction in the BACHD mouse model of Huntington\u2019s disease. PLoS One 11, e0147583 (2016).","journal-title":"PLoS One"},{"key":"577_CR158","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JHD-200411","volume":"9","author":"L Delfino","year":"2020","unstructured":"Delfino, L., Mason, R. P., Kyriacou, C. P., Giorgini, F. & Rosato, E. Rab8 promotes mutant HTT aggregation, reduces neurodegeneration, and ameliorates behavioural alterations in a Drosophila model of Huntington\u2019s disease. J. Huntingt. Dis. 9, 253\u2013263 (2020).","journal-title":"J. Huntingt. Dis."},{"key":"577_CR159","doi-asserted-by":"crossref","first-page":"595","DOI":"10.3390\/cells8060595","volume":"8","author":"L Yu-Taeger","year":"2019","unstructured":"Yu-Taeger, L. et al. Intranasal administration of mesenchymal stem cells ameliorates the abnormal dopamine transmission system and inflammatory reaction in the R6\/2 mouse model of huntington disease. Cells 8, 595 (2019).","journal-title":"Cells"},{"key":"577_CR160","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12699","volume":"31","author":"O Rudenko","year":"2019","unstructured":"Rudenko, O. et al. Ghrelin-mediated improvements in the metabolic phenotype in the R6\/2 mouse model of Huntington\u2019s disease. J. Neuroendocrinol. 31, e12699 (2019).","journal-title":"J. Neuroendocrinol."},{"key":"577_CR161","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1177\/0748730418790401","volume":"33","author":"DS Whittaker","year":"2018","unstructured":"Whittaker, D. S. et al. Circadian-based treatment strategy effective in the BACHD mouse model of Huntington\u2019s disease. J. Biol. Rhythm. 33, 535\u2013554 (2018).","journal-title":"J. Biol. Rhythm."},{"key":"577_CR162","doi-asserted-by":"publisher","DOI":"10.1523\/ENEURO.0431-17.2017","author":"HB Wang","year":"2018","unstructured":"Wang, H. B. et al. Time-restricted feeding improves circadian dysfunction as well as motor symptoms in the Q175 mouse model of Huntington\u2019s disease. eNeuro https:\/\/doi.org\/10.1523\/ENEURO.0431-17.2017 (2018).","journal-title":"eNeuro"},{"key":"577_CR163","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.nbscr.2016.12.002","volume":"2","author":"HB Wang","year":"2017","unstructured":"Wang, H. B. et al. Blue light therapy improves circadian dysfunction as well as motor symptoms in two mouse models of Huntington\u2019s disease. Neurobiol. Sleep Circadian Rhythm. 2, 39\u201352 (2017).","journal-title":"Neurobiol. Sleep Circadian Rhythm."},{"key":"577_CR164","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.nbscr.2016.11.004","volume":"2","author":"K Ouk","year":"2017","unstructured":"Ouk, K., Aungier, J. & Morton, A. J. Prolonged day length exposure improves circadian deficits and survival in a transgenic mouse model of Huntington\u2019s disease. Neurobiol. Sleep Circadian Rhythm. 2, 27\u201338 (2017).","journal-title":"Neurobiol. Sleep Circadian Rhythm."},{"key":"577_CR165","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.nbd.2013.11.008","volume":"63","author":"M Cuesta","year":"2014","unstructured":"Cuesta, M., Aungier, J. & Morton, A. J. Behavioral therapy reverses circadian deficits in a transgenic mouse model of Huntington\u2019s disease. Neurobiol. Dis. 63, 85\u201391 (2014).","journal-title":"Neurobiol. Dis."},{"key":"577_CR166","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2217\/nmt.15.45","volume":"5","author":"DJ van Wamelen","year":"2015","unstructured":"van Wamelen, D. J., Roos, R. A. & Aziz, N. A. Therapeutic strategies for circadian rhythm and sleep disturbances in Huntington disease. Neurodegener. Dis. Manag. 5, 549\u2013555 (2015).","journal-title":"Neurodegener. Dis. Manag."},{"key":"577_CR167","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1176\/ajp.133.10.1181","volume":"133","author":"JS Carman","year":"1976","unstructured":"Carman, J. S., Post, R. M., Buswell, R. & Goodwin, F. K. Negative effects of melatonin on depression. Am. J. Psychiatry 133, 1181\u20131186 (1976).","journal-title":"Am. J. Psychiatry"},{"key":"577_CR168","doi-asserted-by":"crossref","first-page":"116522","DOI":"10.1016\/j.jns.2019.116522","volume":"408","author":"DM Bartlett","year":"2020","unstructured":"Bartlett, D. M. et al. Multidisciplinary rehabilitation reduces hypothalamic grey matter volume loss in individuals with preclinical Huntington\u2019s disease: A nine-month pilot study. J. Neurol. Sci. 408, 116522 (2020).","journal-title":"J. Neurol. Sci."},{"key":"577_CR169","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1111\/j.1460-9568.2006.05059.x","volume":"24","author":"C Rossi","year":"2006","unstructured":"Rossi, C. et al. Brain-derived neurotrophic factor (BDNF) is required for the enhancement of hippocampal neurogenesis following environmental enrichment. Eur. J. Neurosci. 24, 1850\u20131856 (2006).","journal-title":"Eur. J. Neurosci."},{"key":"577_CR170","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/S0140-6736(10)61349-9","volume":"377","author":"C Ballard","year":"2011","unstructured":"Ballard, C. et al. Alzheimer\u2019s disease. Lancet 377, 1019\u20131031 (2011).","journal-title":"Lancet"},{"key":"577_CR171","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/nrn2967","volume":"12","author":"LM Ittner","year":"2011","unstructured":"Ittner, L. M. & Gotz, J. Amyloid-beta and tau \u2014 a toxic pas de deux in Alzheimer\u2019s disease. Nat. Rev. Neurosci. 12, 65\u201372 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"577_CR172","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","volume":"179","author":"JM Long","year":"2019","unstructured":"Long, J. M. & Holtzman, D. M. Alzheimer disease: an update on pathobiology and treatment strategies. Cell 179, 312\u2013339 (2019).","journal-title":"Cell"},{"key":"577_CR173","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","volume":"82","author":"H Braak","year":"1991","unstructured":"Braak, H. & Braak, E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 82, 239\u2013259 (1991).","journal-title":"Acta Neuropathol."},{"key":"577_CR174","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.sleep.2006.11.010","volume":"8","author":"YH Wu","year":"2007","unstructured":"Wu, Y. H. & Swaab, D. F. Disturbance and strategies for reactivation of the circadian rhythm system in aging and Alzheimer\u2019s disease. Sleep Med. 8, 623\u2013636 (2007).","journal-title":"Sleep Med."},{"key":"577_CR175","first-page":"108","volume":"6","author":"A Bianchetti","year":"1995","unstructured":"Bianchetti, A. et al. Predictors of mortality and institutionalization in Alzheimer disease patients 1 year after discharge from an Alzheimer dementia unit. Dementia 6, 108\u2013112 (1995).","journal-title":"Dementia"},{"key":"577_CR176","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/089198879100400405","volume":"4","author":"CP Pollak","year":"1991","unstructured":"Pollak, C. P. & Perlick, D. Sleep problems and institutionalization of the elderly. J. Geriatr. Psychiatry Neurol. 4, 204\u2013210 (1991).","journal-title":"J. Geriatr. Psychiatry Neurol."},{"key":"577_CR177","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41593-018-0126-0","volume":"21","author":"WD Todd","year":"2018","unstructured":"Todd, W. D. et al. A hypothalamic circuit for the circadian control of aggression. Nat. Neurosci. 21, 717\u2013724 (2018).","journal-title":"Nat. Neurosci."},{"key":"577_CR178","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3109\/07420528.2015.1124885","volume":"33","author":"T Paillard","year":"2016","unstructured":"Paillard, T., Noe, F., Bru, N., Couderc, M. & Debove, L. The impact of time of day on the gait and balance control of Alzheimer\u2019s patients. Chronobiol. Int. 33, 161\u2013168 (2016).","journal-title":"Chronobiol. Int."},{"key":"577_CR179","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neurobiolaging.2003.04.009","volume":"25","author":"DG Harper","year":"2004","unstructured":"Harper, D. G. et al. Dementia severity and Lewy bodies affect circadian rhythms in Alzheimer disease. Neurobiol. Aging 25, 771\u2013781 (2004).","journal-title":"Neurobiol. Aging"},{"key":"577_CR180","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1001\/jamaneurol.2017.4719","volume":"75","author":"ES Musiek","year":"2018","unstructured":"Musiek, E. S. et al. Circadian rest-activity pattern changes in aging and preclinical Alzheimer disease. JAMA Neurol. 75, 582\u2013590 (2018). This study examined changes in circadian rest\u2013activity patterns in preclinical AD compared with normal ageing.","journal-title":"JAMA Neurol."},{"key":"577_CR181","doi-asserted-by":"crossref","first-page":"524971","DOI":"10.1155\/2014\/524971","volume":"2014","author":"E Ortiz-Tudela","year":"2014","unstructured":"Ortiz-Tudela, E. et al. The characterization of biological rhythms in mild cognitive impairment. Biomed. Res. Int. 2014, 524971 (2014).","journal-title":"Biomed. Res. Int."},{"key":"577_CR182","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3233\/JAD-131217","volume":"38","author":"SL Naismith","year":"2014","unstructured":"Naismith, S. L. et al. Circadian misalignment and sleep disruption in mild cognitive impairment. J. Alzheimers Dis. 38, 857\u2013866 (2014).","journal-title":"J. Alzheimers Dis."},{"key":"577_CR183","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1001\/jamaneurol.2013.2334","volume":"70","author":"YE Ju","year":"2013","unstructured":"Ju, Y. E. et al. Sleep quality and preclinical Alzheimer disease. JAMA Neurol. 70, 587\u2013593 (2013).","journal-title":"JAMA Neurol."},{"key":"577_CR184","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/ana.24432","volume":"78","author":"JL Wang","year":"2015","unstructured":"Wang, J. L. et al. Suprachiasmatic neuron numbers and rest-activity circadian rhythms in older humans. Ann. Neurol. 78, 317\u2013322 (2015).","journal-title":"Ann. Neurol."},{"key":"577_CR185","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0146200","volume":"11","author":"K Weissova","year":"2016","unstructured":"Weissova, K., Bartos, A., Sladek, M., Novakova, M. & Sumova, A. Moderate changes in the circadian system of Alzheimer\u2019s disease patients detected in their home environment. PLoS One 11, e0146200 (2016).","journal-title":"PLoS One"},{"key":"577_CR186","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/WAD.0000000000000037","volume":"29","author":"AM Hooghiemstra","year":"2015","unstructured":"Hooghiemstra, A. M., Eggermont, L. H., Scheltens, P., van der Flier, W. M. & Scherder, E. J. The rest-activity rhythm and physical activity in early-onset dementia. Alzheimer Dis. Assoc. Disord. 29, 45\u201349 (2015).","journal-title":"Alzheimer Dis. Assoc. Disord."},{"key":"577_CR187","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/jamaneurol.2014.2510","volume":"71","author":"C Liguori","year":"2014","unstructured":"Liguori, C. et al. Orexinergic system dysregulation, sleep impairment, and cognitive decline in Alzheimer disease. JAMA Neurol. 71, 1498\u20131505 (2014).","journal-title":"JAMA Neurol."},{"key":"577_CR188","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/0006-3223(90)90523-5","volume":"27","author":"W Witting","year":"1990","unstructured":"Witting, W., Kwa, I. H., Eikelenboom, P., Mirmiran, M. & Swaab, D. F. Alterations in the circadian rest-activity rhythm in aging and Alzheimer\u2019s disease. Biol. Psychiatry 27, 563\u2013572 (1990).","journal-title":"Biol. Psychiatry"},{"key":"577_CR189","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0006-3223(95)00370-3","volume":"40","author":"EJ van Someren","year":"1996","unstructured":"van Someren, E. J. et al. Circadian rest-activity rhythm disturbances in Alzheimer\u2019s disease. Biol. Psychiatry 40, 259\u2013270 (1996).","journal-title":"Biol. Psychiatry"},{"key":"577_CR190","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1002\/ana.22468","volume":"70","author":"GJ Tranah","year":"2011","unstructured":"Tranah, G. J. et al. Circadian activity rhythms and risk of incident dementia and mild cognitive impairment in older women. Ann. Neurol. 70, 722\u2013732 (2011).","journal-title":"Ann. Neurol."},{"key":"577_CR191","first-page":"1030","volume":"14","author":"EJ Wams","year":"2017","unstructured":"Wams, E. J., Wilcock, G. K., Foster, R. G. & Wulff, K. Sleep-wake patterns and cognition of older adults with amnestic mild cognitive impairment (aMCI): a comparison with cognitively healthy adults and moderate Alzheimer\u2019s disease patients. Curr. Alzheimer Res. 14, 1030\u20131041 (2017).","journal-title":"Curr. Alzheimer Res."},{"key":"577_CR192","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0197-4580(95)00059-N","volume":"16","author":"A Satlin","year":"1995","unstructured":"Satlin, A., Volicer, L., Stopa, E. G. & Harper, D. Circadian locomotor activity and core-body temperature rhythms in Alzheimer\u2019s disease. Neurobiol. Aging 16, 765\u2013771 (1995).","journal-title":"Neurobiol. Aging"},{"key":"577_CR193","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00019442-200505000-00004","volume":"13","author":"DG Harper","year":"2005","unstructured":"Harper, D. G. et al. Disturbance of endogenous circadian rhythm in aging and Alzheimer disease. Am. J. Geriatr. Psychiatry 13, 359\u2013368 (2005).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"577_CR194","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnagi.2017.00093","volume":"9","author":"C Abulafia","year":"2017","unstructured":"Abulafia, C. et al. Relationship between cognitive and sleep-wake variables in asymptomatic offspring of patients with late-onset Alzheimer\u2019s disease. Front. Aging Neurosci. 9, 93 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"577_CR195","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1007\/s00702-012-0864-1","volume":"119","author":"EI Most","year":"2012","unstructured":"Most, E. I., Scheltens, P. & Van Someren, E. J. Increased skin temperature in Alzheimer\u2019s disease is associated with sleepiness. J. Neural Transm. 119, 1185\u20131194 (2012).","journal-title":"J. Neural Transm."},{"key":"577_CR196","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.neuroscience.2007.03.058","volume":"149","author":"K Hu","year":"2007","unstructured":"Hu, K., Scheer, F. A., Ivanov, P., Buijs, R. M. & Shea, S. A. The suprachiasmatic nucleus functions beyond circadian rhythm generation. Neuroscience 149, 508\u2013517 (2007).","journal-title":"Neuroscience"},{"key":"577_CR197","doi-asserted-by":"crossref","first-page":"2490","DOI":"10.1073\/pnas.0806087106","volume":"106","author":"K Hu","year":"2009","unstructured":"Hu, K., Van Someren, E. J., Shea, S. A. & Scheer, F. A. Reduction of scale invariance of activity fluctuations with aging and Alzheimer\u2019s disease: Involvement of the circadian pacemaker. Proc. Natl Acad. Sci. USA 106, 2490\u20132494 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"577_CR198","volume":"3","author":"K Hu","year":"2013","unstructured":"Hu, K., Harper, D. G., Shea, S. A., Stopa, E. G. & Scheer, F. A. Noninvasive fractal biomarker of clock neurotransmitter disturbance in humans with dementia. Sci. Rep. 3, 2229 (2013).","journal-title":"Sci. Rep."},{"key":"577_CR199","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neurobiolaging.2019.08.023","volume":"83","author":"P Li","year":"2019","unstructured":"Li, P. et al. Interaction between the progression of Alzheimer\u2019s disease and fractal degradation. Neurobiol. Aging 83, 21\u201330 (2019). This study examined fractal degradation in AD and demonstrated its degradation throughout the course of AD.","journal-title":"Neurobiol. Aging"},{"key":"577_CR200","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S0531-5565(02)00198-5","volume":"38","author":"DJ Skene","year":"2003","unstructured":"Skene, D. J. & Swaab, D. F. Melatonin rhythmicity: effect of age and Alzheimer\u2019s disease. Exp. Gerontol. 38, 199\u2013206 (2003).","journal-title":"Exp. Gerontol."},{"key":"577_CR201","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1600-079X.2011.00937.x","volume":"52","author":"SA Rosales-Corral","year":"2012","unstructured":"Rosales-Corral, S. A. et al. Alzheimer\u2019s disease: pathological mechanisms and the beneficial role of melatonin. J. Pineal Res. 52, 167\u2013202 (2012).","journal-title":"J. Pineal Res."},{"key":"577_CR202","doi-asserted-by":"crossref","first-page":"14575","DOI":"10.3390\/ijms140714575","volume":"14","author":"L Lin","year":"2013","unstructured":"Lin, L. et al. Melatonin in Alzheimer\u2019s disease. Int. J. Mol. Sci. 14, 14575\u201314593 (2013).","journal-title":"Int. J. Mol. Sci."},{"key":"577_CR203","first-page":"323","volume":"84","author":"RY Liu","year":"1999","unstructured":"Liu, R. Y., Zhou, J. N., van Heerikhuize, J., Hofman, M. A. & Swaab, D. F. Decreased melatonin levels in postmortem cerebrospinal fluid in relation to aging, Alzheimer\u2019s disease, and apolipoprotein E-\u03b54\/4 genotype. J. Clin. Endocrinol. Metab. 84, 323\u2013327 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"577_CR204","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.sleep.2019.04.018","volume":"63","author":"R Manni","year":"2019","unstructured":"Manni, R. et al. Evening melatonin timing secretion in real life conditions in patients with Alzheimer disease of mild to moderate severity. Sleep Med. 63, 122\u2013126 (2019).","journal-title":"Sleep Med."},{"key":"577_CR205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1034\/j.1600-079X.2003.00065.x","volume":"35","author":"JN Zhou","year":"2003","unstructured":"Zhou, J. N., Liu, R. Y., Kamphorst, W., Hofman, M. A. & Swaab, D. F. Early neuropathological Alzheimer\u2019s changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels. J. Pineal Res. 35, 125\u2013130 (2003).","journal-title":"J. Pineal Res."},{"key":"577_CR206","doi-asserted-by":"crossref","first-page":"5898","DOI":"10.1210\/jc.2003-030833","volume":"88","author":"YH Wu","year":"2003","unstructured":"Wu, Y. H. et al. Molecular changes underlying reduced pineal melatonin levels in Alzheimer disease: alterations in preclinical and clinical stages. J. Clin. Endocrinol. Metab. 88, 5898\u20135906 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"577_CR207","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0006-3223(97)00510-6","volume":"45","author":"K Mishima","year":"1999","unstructured":"Mishima, K. et al. Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer\u2019s type with disturbed sleep-waking. Biol. Psychiatry 45, 417\u2013421 (1999).","journal-title":"Biol. Psychiatry"},{"key":"577_CR208","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1016\/j.neurobiolaging.2011.12.026","volume":"33","author":"L Shan","year":"2012","unstructured":"Shan, L., Bossers, K., Unmehopa, U., Bao, A. M. & Swaab, D. F. Alterations in the histaminergic system in Alzheimer\u2019s disease: a postmortem study. Neurobiol. Aging 33, 2585\u20132598 (2012).","journal-title":"Neurobiol. Aging"},{"key":"577_CR209","doi-asserted-by":"crossref","first-page":"713","DOI":"10.5665\/sleep.1838","volume":"35","author":"L Shan","year":"2012","unstructured":"Shan, L. et al. Diurnal fluctuation in histidine decarboxylase expression, the rate limiting enzyme for histamine production, and its disorder in neurodegenerative diseases. Sleep 35, 713\u2013715 (2012).","journal-title":"Sleep"},{"key":"577_CR210","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neuint.2019.04.015","volume":"128","author":"J Janssens","year":"2019","unstructured":"Janssens, J. et al. Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient. Neurochem. Int. 128, 154\u2013162 (2019).","journal-title":"Neurochem. Int."},{"key":"577_CR211","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13024-017-0161-4","volume":"12","author":"BP Lucey","year":"2017","unstructured":"Lucey, B. P., Fagan, A. M., Holtzman, D. M., Morris, J. C. & Bateman, R. J. Diurnal oscillation of CSF A\u03b2 and other AD biomarkers. Mol. Neurodegener. 12, 36 (2017).","journal-title":"Mol. Neurodegener."},{"key":"577_CR212","first-page":"291","volume":"11","author":"M Rozga","year":"2019","unstructured":"Rozga, M., Bittner, T., Batrla, R. & Karl, J. Preanalytical sample handling recommendations for Alzheimer\u2019s disease plasma biomarkers. Alzheimers Dement. 11, 291\u2013300 (2019).","journal-title":"Alzheimers Dement."},{"key":"577_CR213","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","volume":"326","author":"JE Kang","year":"2009","unstructured":"Kang, J. E. et al. Amyloid-\u03b2 dynamics are regulated by orexin and the sleep-wake cycle. Science 326, 1005\u20131007 (2009). This study demonstrated influences of the sleep\u2013wake cycles and orexin system on A\u03b2 dynamics.","journal-title":"Science"},{"key":"577_CR214","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1177\/1533317514556876","volume":"30","author":"SJ Baloyannis","year":"2015","unstructured":"Baloyannis, S. J., Mavroudis, I., Mitilineos, D., Baloyannis, I. S. & Costa, V. G. The hypothalamus in Alzheimer\u2019s disease: a Golgi and electron microscope study. Am. J. Alzheimers Dis. Other Demen. 30, 478\u2013487 (2015).","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"577_CR215","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neurobiolaging.2006.06.002","volume":"28","author":"YH Wu","year":"2007","unstructured":"Wu, Y. H., Zhou, J. N., Van Heerikhuize, J., Jockers, R. & Swaab, D. F. Decreased MT1 melatonin receptor expression in the suprachiasmatic nucleus in aging and Alzheimer\u2019s disease. Neurobiol. Aging 28, 1239\u20131247 (2007).","journal-title":"Neurobiol. Aging"},{"key":"577_CR216","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00005072-199901000-00004","volume":"58","author":"EG Stopa","year":"1999","unstructured":"Stopa, E. G. et al. Pathologic evaluation of the human suprachiasmatic nucleus in severe dementia. J. Neuropathol. Exp. Neurol. 58, 29\u201339 (1999).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"577_CR217","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0306-4522(00)00583-2","volume":"103","author":"AN Coogan","year":"2001","unstructured":"Coogan, A. N., Rawlings, N., Luckman, S. M. & Piggins, H. D. Effects of neurotensin on discharge rates of rat suprachiasmatic nucleus neurons in vitro. Neuroscience 103, 663\u2013672 (2001).","journal-title":"Neuroscience"},{"key":"577_CR218","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0197-4580(95)00043-E","volume":"16","author":"JN Zhou","year":"1995","unstructured":"Zhou, J. N., Hofman, M. A. & Swaab, D. F. VIP neurons in the human SCN in relation to sex, age, and Alzheimer\u2019s disease. Neurobiol. Aging 16, 571\u2013576 (1995).","journal-title":"Neurobiol. Aging"},{"key":"577_CR219","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1093\/jnen\/59.4.314","volume":"59","author":"RY Liu","year":"2000","unstructured":"Liu, R. Y. et al. Decreased vasopressin gene expression in the biological clock of Alzheimer disease patients with and without depression. J. Neuropathol. Exp. Neurol. 59, 314\u2013322 (2000).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"577_CR220","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.24548","volume":"79","author":"C La Morgia","year":"2016","unstructured":"La Morgia, C. et al. Melanopsin retinal ganglion cell loss in Alzheimer disease. Ann. Neurol. 79, 90\u2013109 (2016).","journal-title":"Ann. Neurol."},{"key":"577_CR221","volume":"14","author":"AJ Oh","year":"2019","unstructured":"Oh, A. J. et al. Pupillometry evaluation of melanopsin retinal ganglion cell function and sleep-wake activity in pre-symptomatic Alzheimer\u2019s disease. PLoS One 14, e0226197 (2019).","journal-title":"PLoS One"},{"key":"577_CR222","doi-asserted-by":"crossref","first-page":"780","DOI":"10.3389\/fnins.2020.00780","volume":"14","author":"M Romagnoli","year":"2020","unstructured":"Romagnoli, M. et al. Chromatic pupillometry findings in Alzheimer\u2019s disease. Front. Neurosci. 14, 780 (2020). This study reported ambormailities in the pupillary light response in early AD.","journal-title":"Front. Neurosci."},{"key":"577_CR223","doi-asserted-by":"crossref","first-page":"R128","DOI":"10.1093\/hmg\/ddx240","volume":"26","author":"A Jagannath","year":"2017","unstructured":"Jagannath, A., Taylor, L., Wakaf, Z., Vasudevan, S. R. & Foster, R. G. The genetics of circadian rhythms, sleep and health. Hum. Mol. Genet. 26, R128\u2013R138 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"577_CR224","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.jsmc.2015.08.007","volume":"10","author":"TS Andreani","year":"2015","unstructured":"Andreani, T. S., Itoh, T. Q., Yildirim, E., Hwangbo, D. S. & Allada, R. Genetics of circadian rhythms. Sleep Med. Clin. 10, 413\u2013421 (2015).","journal-title":"Sleep Med. Clin."},{"key":"577_CR225","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jalz.2016.10.003","volume":"13","author":"P Cronin","year":"2017","unstructured":"Cronin, P. et al. Circadian alterations during early stages of Alzheimer\u2019s disease are associated with aberrant cycles of DNA methylation in BMAL1. Alzheimers Dement. 13, 689\u2013700 (2017).","journal-title":"Alzheimers Dement."},{"key":"577_CR226","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.3233\/JAD-200634","volume":"77","author":"B Hulme","year":"2020","unstructured":"Hulme, B. et al. Epigenetic regulation of BMAL1 with sleep disturbances and Alzheimer\u2019s disease. J. Alzheimers Dis. 77, 1783\u20131792 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"577_CR227","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1096\/fj.05-4446fje","volume":"20","author":"YH Wu","year":"2006","unstructured":"Wu, Y. H. et al. Pineal clock gene oscillation is disturbed in Alzheimer\u2019s disease, due to functional disconnection from the \u201cmaster clock\u201d. FASEB J. 20, 1874\u20131876 (2006).","journal-title":"FASEB J."},{"key":"577_CR228","doi-asserted-by":"crossref","first-page":"zsy103","DOI":"10.1093\/sleep\/zsy103","volume":"41","author":"S Sulkava","year":"2018","unstructured":"Sulkava, S. et al. Melatonin receptor type 1A gene linked to Alzheimer\u2019s disease in old age. Sleep 41, zsy103 (2018).","journal-title":"Sleep"},{"key":"577_CR229","doi-asserted-by":"crossref","first-page":"e1167","DOI":"10.1212\/WNL.0000000000005193","volume":"90","author":"JY Hwang","year":"2018","unstructured":"Hwang, J. Y. et al. Moderating effect of APOE \u03b54 on the relationship between sleep-wake cycle and brain \u03b2-amyloid. Neurology 90, e1167\u2013e1173 (2018).","journal-title":"Neurology"},{"key":"577_CR230","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.brainres.2017.01.033","volume":"1660","author":"L Navigatore-Fonzo","year":"2017","unstructured":"Navigatore-Fonzo, L. et al. Daily rhythms of cognition-related factors are modified in an experimental model of Alzheimer\u2019s disease. Brain Res. 1660, 27\u201335 (2017).","journal-title":"Brain Res."},{"key":"577_CR231","volume":"14","author":"E Baker","year":"2019","unstructured":"Baker, E. et al. Gene-based analysis in HRC imputed genome wide association data identifies three novel genes for Alzheimer\u2019s disease. PLoS One 14, e0218111 (2019).","journal-title":"PLoS One"},{"key":"577_CR232","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.trecan.2016.09.006","volume":"2","author":"C Luo","year":"2016","unstructured":"Luo, C., Widlund, H. R. & Puigserver, P. PGC-1 coactivators: shepherding the mitochondrial biogenesis of tumors. Trends Cancer 2, 619\u2013631 (2016).","journal-title":"Trends Cancer"},{"key":"577_CR233","doi-asserted-by":"crossref","first-page":"12292","DOI":"10.1073\/pnas.1606171113","volume":"113","author":"L Katsouri","year":"2016","unstructured":"Katsouri, L. et al. PPAR\u03b3-coactivator-1\u03b1 gene transfer reduces neuronal loss and amyloid-\u03b2 generation by reducing \u03b2-secretase in an Alzheimer\u2019s disease model. Proc. Natl Acad. Sci. USA 113, 12292\u201312297 (2016).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"577_CR234","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/nature05767","volume":"447","author":"C Liu","year":"2007","unstructured":"Liu, C., Li, S., Liu, T., Borjigin, J. & Lin, J. D. Transcriptional coactivator PGC-1\u03b1 integrates the mammalian clock and energy metabolism. Nature 447, 477\u2013481 (2007).","journal-title":"Nature"},{"key":"577_CR235","doi-asserted-by":"crossref","DOI":"10.1621\/nrs.07003","volume":"7","author":"AM Jetten","year":"2009","unstructured":"Jetten, A. M. Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism. Nucl. Recept. Signal. 7, e003 (2009).","journal-title":"Nucl. Recept. Signal."},{"key":"577_CR236","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2174\/1567205017666200810164932","volume":"17","author":"Y Zhu","year":"2020","unstructured":"Zhu, Y. et al. Exploring shared pathogenesis of Alzheimer\u2019s disease and type 2 diabetes mellitus via co-expression networks analysis. Curr. Alzheimer Res. 17, 566\u2013575 (2020).","journal-title":"Curr. Alzheimer Res."},{"key":"577_CR237","volume":"8","author":"AS Lim","year":"2017","unstructured":"Lim, A. S. et al. Diurnal and seasonal molecular rhythms in human neocortex and their relation to Alzheimer\u2019s disease. Nat. Commun. 8, 14931 (2017).","journal-title":"Nat. Commun."},{"key":"577_CR238","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0896-6273(03)00434-3","volume":"39","author":"S Oddo","year":"2003","unstructured":"Oddo, S. et al. Triple-transgenic model of Alzheimer\u2019s disease with plaques and tangles: intracellular A\u03b2 and synaptic dysfunction. Neuron 39, 409\u2013421 (2003).","journal-title":"Neuron"},{"key":"577_CR239","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.brainres.2010.05.013","volume":"1348","author":"R Sterniczuk","year":"2010","unstructured":"Sterniczuk, R., Dyck, R. H., Laferla, F. M. & Antle, M. C. Characterization of the 3xTg-AD mouse model of Alzheimer\u2019s disease: part 1. Circadian changes. Brain Res. 1348, 139\u2013148 (2010).","journal-title":"Brain Res."},{"key":"577_CR240","first-page":"160","volume":"6","author":"EM Knight","year":"2013","unstructured":"Knight, E. M. et al. Age-related changes in core body temperature and activity in triple-transgenic Alzheimer\u2019s disease (3xTgAD) mice. Dis. Model. Mech. 6, 160\u2013170 (2013).","journal-title":"Dis. Model. Mech."},{"key":"577_CR241","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.neulet.2018.04.008","volume":"676","author":"M Wu","year":"2018","unstructured":"Wu, M. et al. Abnormal circadian locomotor rhythms and Per gene expression in six-month-old triple transgenic mice model of Alzheimer\u2019s disease. Neurosci. Lett. 676, 13\u201318 (2018).","journal-title":"Neurosci. Lett."},{"key":"577_CR242","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.3109\/07420528.2010.485711","volume":"27","author":"MR Gorman","year":"2010","unstructured":"Gorman, M. R. & Yellon, S. Lifespan daily locomotor activity rhythms in a mouse model of amyloid-induced neuropathology. Chronobiol. Int. 27, 1159\u20131177 (2010).","journal-title":"Chronobiol. Int."},{"key":"577_CR243","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/j.neurobiolaging.2005.05.009","volume":"27","author":"O Ambree","year":"2006","unstructured":"Ambree, O. et al. Activity changes and marked stereotypic behavior precede A\u03b2 pathology in TgCRND8 Alzheimer mice. Neurobiol. Aging 27, 955\u2013964 (2006).","journal-title":"Neurobiol. Aging"},{"key":"577_CR244","doi-asserted-by":"crossref","first-page":"795","DOI":"10.3233\/JAD-200331","volume":"77","author":"A Furtado","year":"2020","unstructured":"Furtado, A. et al. The rhythmicity of clock genes is disrupted in the choroid plexus of the APP\/PS1 mouse model of Alzheimer\u2019s disease. J. Alzheimers Dis. 77, 795\u2013806 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"577_CR245","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3389\/fphys.2020.00294","volume":"11","author":"Y Yao","year":"2020","unstructured":"Yao, Y. et al. Non-invasive 40-Hz light flicker ameliorates Alzheimer\u2019s-associated rhythm disorder via regulating central circadian clock in mice. Front. Physiol. 11, 294 (2020).","journal-title":"Front. Physiol."},{"key":"577_CR246","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68199-5","volume":"10","author":"R Nagare","year":"2020","unstructured":"Nagare, R., Possidente, B., Lagalwar, S. & Figueiro, M. G. Robust light-dark patterns and reduced amyloid load in an Alzheimer\u2019s disease transgenic mouse model. Sci. Rep. 10, 11436 (2020). This study showed that increasing light levels might reduce amyloid load in an AD transgenic mouse model.","journal-title":"Sci. Rep."},{"key":"577_CR247","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3233\/JAD-190102","volume":"71","author":"SH Deibel","year":"2019","unstructured":"Deibel, S. H., Young, B., Mohajerani, M. H. & McDonald, R. J. Activity rhythms are largely intact in APPNL-G-F Alzheimer\u2019s disease mice. J. Alzheimers Dis. 71, 213\u2013225 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"577_CR248","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.neurobiolaging.2019.01.010","volume":"78","author":"BA Kent","year":"2019","unstructured":"Kent, B. A. et al. Delayed daily activity and reduced NREM slow-wave power in the APPswe\/PS1dE9 mouse model of Alzheimer\u2019s disease. Neurobiol. Aging 78, 74\u201386 (2019).","journal-title":"Neurobiol. Aging"},{"key":"577_CR249","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3389\/fnagi.2018.00250","volume":"10","author":"T Petrasek","year":"2018","unstructured":"Petrasek, T. et al. The McGill transgenic rat model of Alzheimer\u2019s disease displays cognitive and motor impairments, changes in anxiety and social behavior, and altered circadian activity. Front. Aging Neurosci. 10, 250 (2018).","journal-title":"Front. Aging Neurosci."},{"key":"577_CR250","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.physbeh.2017.09.021","volume":"182","author":"KN Boggs","year":"2017","unstructured":"Boggs, K. N., Kakalec, P. A., Smith, M. L., Howell, S. N. & Flinn, J. M. Circadian wheel running behavior is altered in an APP\/E4 mouse model of late onset Alzheimer\u2019s disease. Physiol. Behav. 182, 137\u2013142 (2017).","journal-title":"Physiol. Behav."},{"key":"577_CR251","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.expneurol.2017.04.015","volume":"294","author":"K Stevanovic","year":"2017","unstructured":"Stevanovic, K. et al. Disruption of normal circadian clock function in a mouse model of tauopathy. Exp. Neurol. 294, 58\u201367 (2017).","journal-title":"Exp. Neurol."},{"key":"577_CR252","doi-asserted-by":"crossref","first-page":"850","DOI":"10.2174\/1567205014666170317113159","volume":"14","author":"O Oyegbami","year":"2017","unstructured":"Oyegbami, O. et al. Abnormal clock gene expression and locomotor activity rhythms in two month-old female APPSwe\/PS1dE9 MICE. Curr. Alzheimer Res. 14, 850\u2013860 (2017).","journal-title":"Curr. Alzheimer Res."},{"key":"577_CR253","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13024-015-0007-x","volume":"10","author":"H Song","year":"2015","unstructured":"Song, H. et al. Abeta-induced degradation of BMAL1 and CBP leads to circadian rhythm disruption in Alzheimer\u2019s disease. Mol. Neurodegener. 10, 13 (2015).","journal-title":"Mol. Neurodegener."},{"key":"577_CR254","doi-asserted-by":"crossref","first-page":"823","DOI":"10.3233\/JAD-132009","volume":"43","author":"JJ Graybeal","year":"2015","unstructured":"Graybeal, J. J. et al. Human ApoE epsilon4 alters circadian rhythm activity, IL-1\u03b2, and GFAP in CRND8 mice. J. Alzheimers Dis. 43, 823\u2013834 (2015).","journal-title":"J. Alzheimers Dis."},{"key":"577_CR255","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03507-2","volume":"9","author":"J Myung","year":"2018","unstructured":"Myung, J. et al. The choroid plexus is an important circadian clock component. Nat. Commun. 9, 1062 (2018).","journal-title":"Nat. Commun."},{"key":"577_CR256","doi-asserted-by":"crossref","first-page":"117906951878376","DOI":"10.1177\/1179069518783762","volume":"12","author":"J Myung","year":"2018","unstructured":"Myung, J., Wu, D., Simonneaux, V. & Lane, T. J. Strong circadian rhythms in the choroid plexus: implications for sleep-independent brain metabolite clearance. J. Exp. Neurosci. 12, 1179069518783762 (2018).","journal-title":"J. Exp. Neurosci."},{"key":"577_CR257","doi-asserted-by":"crossref","first-page":"6813","DOI":"10.3390\/ijms21186813","volume":"21","author":"AC Duarte","year":"2020","unstructured":"Duarte, A. C. et al. Age, sex hormones, and circadian rhythm regulate the expression of amyloid-\u03b2 scavengers at the choroid plexus. Int. J. Mol. Sci. 21, 6813 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"577_CR258","volume":"6","author":"Z Ma","year":"2016","unstructured":"Ma, Z., Jiang, W. & Zhang, E. E. Orexin signaling regulates both the hippocampal clock and the circadian oscillation of Alzheimer\u2019s disease-risk genes. Sci. Rep. 6, 36035 (2016).","journal-title":"Sci. Rep."},{"key":"577_CR259","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.bbi.2020.05.053","volume":"88","author":"LN Woodie","year":"2020","unstructured":"Woodie, L. N. et al. Western diet-induced obesity disrupts the diurnal rhythmicity of hippocampal core clock gene expression in a mouse model. Brain Behav. Immun. 88, 815\u2013825 (2020).","journal-title":"Brain Behav. Immun."},{"key":"577_CR260","doi-asserted-by":"crossref","first-page":"104507","DOI":"10.1016\/j.nbd.2019.104507","volume":"130","author":"E Buhl","year":"2019","unstructured":"Buhl, E., Higham, J. P. & Hodge, J. J. L. Alzheimer\u2019s disease-associated tau alters Drosophila circadian activity, sleep and clock neuron electrophysiology. Neurobiol. Dis. 130, 104507 (2019).","journal-title":"Neurobiol. Dis."},{"key":"577_CR261","doi-asserted-by":"crossref","first-page":"13090","DOI":"10.1074\/jbc.RA118.003319","volume":"293","author":"ND Younan","year":"2018","unstructured":"Younan, N. D., Chen, K. F., Rose, R. S., Crowther, D. C. & Viles, J. H. Prion protein stabilizes amyloid-beta (Abeta) oligomers and enhances A\u03b2 neurotoxicity in a Drosophila model of Alzheimer\u2019s disease. J. Biol. Chem. 293, 13090\u201313099 (2018).","journal-title":"J. Biol. Chem."},{"key":"577_CR262","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.nbd.2015.02.012","volume":"77","author":"MR Blake","year":"2015","unstructured":"Blake, M. R. et al. Manipulations of amyloid precursor protein cleavage disrupt the circadian clock in aging Drosophila. Neurobiol. Dis. 77, 117\u2013126 (2015).","journal-title":"Neurobiol. Dis."},{"key":"577_CR263","first-page":"445","volume":"7","author":"KF Chen","year":"2014","unstructured":"Chen, K. F., Possidente, B., Lomas, D. A. & Crowther, D. C. The central molecular clock is robust in the face of behavioural arrhythmia in a Drosophila model of Alzheimer\u2019s disease. Dis. Model. Mech. 7, 445\u2013458 (2014).","journal-title":"Dis. Model. Mech."},{"key":"577_CR264","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.bpj.2020.07.011","volume":"119","author":"M Hoore","year":"2020","unstructured":"Hoore, M., Khailaie, S., Montaseri, G., Mitra, T. & Meyer-Hermann, M. Mathematical model shows how sleep may affect amyloid-\u03b2 fibrillization. Biophys. J. 119, 862\u2013872 (2020).","journal-title":"Biophys. J."},{"key":"577_CR265","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1084\/jem.20172347","volume":"215","author":"GJ Kress","year":"2018","unstructured":"Kress, G. J. et al. Regulation of amyloid-beta dynamics and pathology by the circadian clock. J. Exp. Med. 215, 1059\u20131068 (2018).","journal-title":"J. Exp. Med."},{"key":"577_CR266","doi-asserted-by":"crossref","first-page":"zsz266","DOI":"10.1093\/sleep\/zsz266","volume":"43","author":"I Guisle","year":"2020","unstructured":"Guisle, I. et al. Circadian and sleep\/wake-dependent variations in tau phosphorylation are driven by temperature. Sleep 43, zsz266 (2020).","journal-title":"Sleep"},{"key":"577_CR267","volume":"19","author":"J Lee","year":"2020","unstructured":"Lee, J. et al. Inhibition of REV-ERBs stimulates microglial amyloid-beta clearance and reduces amyloid plaque deposition in the 5XFAD mouse model of Alzheimer\u2019s disease. Aging Cell 19, e13078 (2020).","journal-title":"Aging Cell"},{"key":"577_CR268","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1007\/s10654-018-0430-8","volume":"33","author":"K Bokenberger","year":"2018","unstructured":"Bokenberger, K. et al. Shift work and risk of incident dementia: a study of two population-based cohorts. Eur. J. Epidemiol. 33, 977\u2013987 (2018).","journal-title":"Eur. J. Epidemiol."},{"key":"577_CR269","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.smrv.2017.06.010","volume":"40","author":"L Shi","year":"2018","unstructured":"Shi, L. et al. Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med. Rev. 40, 4\u201316 (2018).","journal-title":"Sleep Med. Rev."},{"key":"577_CR270","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1745-7254.2006.00260.x","volume":"27","author":"JZ Wang","year":"2006","unstructured":"Wang, J. Z. & Wang, Z. F. Role of melatonin in Alzheimer-like neurodegeneration. Acta Pharmacol. Sin. 27, 41\u201349 (2006).","journal-title":"Acta Pharmacol. Sin."},{"key":"577_CR271","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.arr.2012.04.003","volume":"12","author":"D Slats","year":"2013","unstructured":"Slats, D., Claassen, J. A., Verbeek, M. M. & Overeem, S. Reciprocal interactions between sleep, circadian rhythms and Alzheimer\u2019s disease: focus on the role of hypocretin and melatonin. Ageing Res. Rev. 12, 188\u2013200 (2013).","journal-title":"Ageing Res. Rev."},{"key":"577_CR272","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.2174\/1570159X15666170313123454","volume":"15","author":"M Shukla","year":"2017","unstructured":"Shukla, M., Govitrapong, P., Boontem, P., Reiter, R. J. & Satayavivad, J. Mechanisms of melatonin in alleviating Alzheimer\u2019s disease. Curr. Neuropharmacol. 15, 1010\u20131031 (2017).","journal-title":"Curr. Neuropharmacol."},{"key":"577_CR273","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nrneurol.2013.269","volume":"10","author":"YE Ju","year":"2014","unstructured":"Ju, Y. E., Lucey, B. P. & Holtzman, D. M. Sleep and Alzheimer disease pathology \u2014 a bidirectional relationship. Nat. Rev. Neurol. 10, 115\u2013119 (2014).","journal-title":"Nat. Rev. Neurol."},{"key":"577_CR274","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1126\/science.aaw5583","volume":"363","author":"W Noble","year":"2019","unstructured":"Noble, W. & Spires-Jones, T. L. Sleep well to slow Alzheimer\u2019s progression? Science 363, 813\u2013814 (2019).","journal-title":"Science"},{"key":"577_CR275","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/S1474-4422(18)30450-2","volume":"18","author":"MR Irwin","year":"2019","unstructured":"Irwin, M. R. & Vitiello, M. V. Implications of sleep disturbance and inflammation for Alzheimer\u2019s disease dementia. Lancet Neurol. 18, 296\u2013306 (2019).","journal-title":"Lancet Neurol."},{"key":"577_CR276","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1272\/jnms.70.334","volume":"70","author":"K Asayama","year":"2003","unstructured":"Asayama, K. et al. Double blind study of melatonin effects on the sleep-wake rhythm, cognitive and non-cognitive functions in Alzheimer type dementia. J. Nippon Med. Sch. 70, 334\u2013341 (2003).","journal-title":"J. Nippon Med. Sch."},{"key":"577_CR277","doi-asserted-by":"crossref","first-page":"218","DOI":"10.2174\/157015910792246209","volume":"8","author":"DP Cardinali","year":"2010","unstructured":"Cardinali, D. P., Furio, A. M. & Brusco, L. I. Clinical aspects of melatonin intervention in Alzheimer\u2019s disease progression. Curr. Neuropharmacol. 8, 218\u2013227 (2010).","journal-title":"Curr. Neuropharmacol."},{"key":"577_CR278","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/j.1532-5415.2007.01543.x","volume":"56","author":"GA Dowling","year":"2008","unstructured":"Dowling, G. A. et al. Melatonin and bright-light treatment for rest-activity disruption in institutionalized patients with Alzheimer\u2019s disease. J. Am. Geriatr. Soc. 56, 239\u2013246 (2008).","journal-title":"J. Am. Geriatr. Soc."},{"key":"577_CR279","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1007\/s00391-007-0420-z","volume":"40","author":"R Mahlberg","year":"2007","unstructured":"Mahlberg, R. & Walther, S. Actigraphy in agitated patients with dementia. Monitoring treatment outcomes. Z. Gerontol. Geriatr. 40, 178\u2013184 (2007).","journal-title":"Z. Gerontol. Geriatr."},{"key":"577_CR280","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1093\/sleep\/26.7.893","volume":"26","author":"C Singer","year":"2003","unstructured":"Singer, C. et al. A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer\u2019s disease. Sleep 26, 893\u2013901 (2003).","journal-title":"Sleep"},{"key":"577_CR281","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/JGP.0b013e318187de18","volume":"17","author":"PR Gehrman","year":"2009","unstructured":"Gehrman, P. R. et al. Melatonin fails to improve sleep or agitation in double-blind randomized placebo-controlled trial of institutionalized patients with Alzheimer disease. Am. J. Geriatr. Psychiatry 17, 166\u2013169 (2009).","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"577_CR282","first-page":"CD003802","volume":"1","author":"SL Jansen","year":"2006","unstructured":"Jansen, S. L., Forbes, D. A., Duncan, V. & Morgan, D. G. Melatonin for cognitive impairment. Cochrane Database Syst. Rev. 1, CD003802 (2006).","journal-title":"Cochrane Database Syst. Rev."},{"key":"577_CR283","first-page":"CD009178","volume":"11","author":"J McCleery","year":"2016","unstructured":"McCleery, J., Cohen, D. A. & Sharpley, A. L. Pharmacotherapies for sleep disturbances in dementia. Cochrane Database Syst. Rev. 11, CD009178 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"key":"577_CR284","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.neurol.2020.06.009","volume":"177","author":"MF Vecchierini","year":"2020","unstructured":"Vecchierini, M. F., Kilic-Huck, U. & Quera-Salva, M. A., Members of the MEL Consensus Group of the SFRMS. Melatonin (MEL) and its use in neurological diseases and insomnia: recommendations of the French Medical and Research Sleep Society (SFRMS). Rev. Neurol. 177, 245\u2013259 (2020).","journal-title":"Rev. Neurol."},{"key":"577_CR285","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/(SICI)1099-1166(199907)14:7<520::AID-GPS983>3.0.CO;2-M","volume":"14","author":"CG Lyketsos","year":"1999","unstructured":"Lyketsos, C. G., Lindell Veiel, L., Baker, A. & Steele, C. A randomized, controlled trial of bright light therapy for agitated behaviors in dementia patients residing in long-term care. Int. J. Geriatr. Psychiatry 14, 520\u2013525 (1999).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"577_CR286","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1207\/S15402010BSM0101_4","volume":"1","author":"S Ancoli-Israel","year":"2003","unstructured":"Ancoli-Israel, S. et al. Increased light exposure consolidates sleep and strengthens circadian rhythms in severe Alzheimer\u2019s disease patients. Behav. Sleep Med. 1, 22\u201336 (2003).","journal-title":"Behav. Sleep Med."},{"key":"577_CR287","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1017\/S1041610209008886","volume":"21","author":"A Burns","year":"2009","unstructured":"Burns, A., Allen, H., Tomenson, B., Duignan, D. & Byrne, J. Bright light therapy for agitation in dementia: a randomized controlled trial. Int. Psychogeriatr. 21, 711\u2013721 (2009).","journal-title":"Int. Psychogeriatr."},{"key":"577_CR288","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1111\/j.1532-5415.2011.03519.x","volume":"59","author":"SM McCurry","year":"2011","unstructured":"McCurry, S. M. et al. Increasing walking and bright light exposure to improve sleep in community-dwelling persons with Alzheimer\u2019s disease: results of a randomized, controlled trial. J. Am. Geriatr. Soc. 59, 1393\u20131402 (2011).","journal-title":"J. Am. Geriatr. Soc."},{"key":"577_CR289","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1017\/S1041610205001584","volume":"17","author":"GA Dowling","year":"2005","unstructured":"Dowling, G. A. et al. Effect of morning bright light treatment for rest-activity disruption in institutionalized patients with severe Alzheimer\u2019s disease. Int. Psychogeriatr. 17, 221\u2013236 (2005).","journal-title":"Int. Psychogeriatr."},{"key":"577_CR290","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/gps.1352","volume":"20","author":"GA Dowling","year":"2005","unstructured":"Dowling, G. A., Mastick, J., Hubbard, E. M., Luxenberg, J. S. & Burr, R. L. Effect of timed bright light treatment for rest-activity disruption in institutionalized patients with Alzheimer\u2019s disease. Int. J. Geriatr. Psychiatry 20, 738\u2013743 (2005).","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"577_CR291","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.5664\/jcsm.8078","volume":"15","author":"MG Figueiro","year":"2019","unstructured":"Figueiro, M. G. et al. Effects of a tailored lighting intervention on sleep quality, rest-activity, mood, and behavior in older adults with alzheimer disease and related dementias: a randomized clinical trial. J. Clin. Sleep Med. 15, 1757\u20131767 (2019).","journal-title":"J. Clin. Sleep Med."},{"key":"577_CR292","doi-asserted-by":"crossref","first-page":"110641","DOI":"10.1016\/j.exger.2019.110641","volume":"124","author":"V Bromundt","year":"2019","unstructured":"Bromundt, V. et al. Effects of a dawn-dusk simulation on circadian rest-activity cycles, sleep, mood and well-being in dementia patients. Exp. Gerontol. 124, 110641 (2019).","journal-title":"Exp. Gerontol."},{"key":"577_CR293","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1159\/000494921","volume":"46","author":"M Mitolo","year":"2018","unstructured":"Mitolo, M. et al. Effects of light treatment on sleep, cognition, mood, and behavior in Alzheimer\u2019s disease: a systematic review. Dement. Geriatr. Cogn. Disord. 46, 371\u2013384 (2018).","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"577_CR294","doi-asserted-by":"crossref","first-page":"993","DOI":"10.3233\/JAD-200252","volume":"75","author":"M Fiala","year":"2020","unstructured":"Fiala, M. et al. Omega-3 fatty acids increase amyloid-beta immunity, energy, and circadian rhythm for cognitive protection of Alzheimer\u2019s disease patients beyond cholinesterase inhibitors. J. Alzheimers Dis. 75, 993\u20131002 (2020).","journal-title":"J. Alzheimers Dis."},{"key":"577_CR295","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3233\/JAD-160392","volume":"53","author":"M Venturelli","year":"2016","unstructured":"Venturelli, M. et al. Effectiveness of exercise- and cognitive-based treatments on salivary cortisol levels and sundowning syndrome symptoms in patients with Alzheimer\u2019s disease. J. Alzheimers Dis. 53, 1631\u20131640 (2016).","journal-title":"J. Alzheimers Dis."},{"key":"577_CR296","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.neurobiolaging.2020.02.020","volume":"91","author":"F Zhou","year":"2020","unstructured":"Zhou, F. et al. Suvorexant ameliorates cognitive impairments and pathology in APP\/PS1 transgenic mice. Neurobiol. Aging 91, 66\u201375 (2020).","journal-title":"Neurobiol. Aging"},{"key":"577_CR297","volume":"9","author":"S Sundaram","year":"2019","unstructured":"Sundaram, S. et al. Inhibition of casein kinase 1delta\/epsilonimproves cognitive-affective behavior and reduces amyloid load in the APP-PS1 mouse model of Alzheimer\u2019s disease. Sci. Rep. 9, 13743 (2019).","journal-title":"Sci. Rep."},{"key":"577_CR298","doi-asserted-by":"crossref","first-page":"3383","DOI":"10.1021\/acs.jproteome.9b00312","volume":"18","author":"P Adler","year":"2019","unstructured":"Adler, P., Mayne, J., Walker, K., Ning, Z. & Figeys, D. Therapeutic targeting of casein kinase 1delta\/epsilon in an Alzheimer\u2019s disease mouse model. J. Proteome Res. 18, 3383\u20133393 (2019).","journal-title":"J. Proteome Res."},{"key":"577_CR299","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/cns.13211","volume":"26","author":"L Wang","year":"2020","unstructured":"Wang, L. et al. D-Ser2-oxyntomodulin ameliorated A\u03b231-35-induced circadian rhythm disorder in mice. CNS Neurosci. Ther. 26, 343\u2013354 (2020).","journal-title":"CNS Neurosci. Ther."},{"key":"577_CR300","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.3390\/nu11071631","volume":"11","author":"YC Chan","year":"2019","unstructured":"Chan, Y. C., Wu, C. S., Wu, T. C., Lin, Y. H. & Chang, S. J. A standardized extract of Asparagus officinalis stem (ETAS\u00ae) ameliorates cognitive impairment, inhibits amyloid beta deposition via BACE-1 and normalizes circadian rhythm signaling via MT1 and MT2. Nutrients 11, 1631 (2019).","journal-title":"Nutrients"},{"key":"577_CR301","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00461-4","volume":"386","author":"J Bang","year":"2015","unstructured":"Bang, J., Spina, S. & Miller, B. L. Frontotemporal dementia. Lancet 386, 1672\u20131682 (2015).","journal-title":"Lancet"},{"key":"577_CR302","doi-asserted-by":"crossref","first-page":"130","DOI":"10.3109\/09540261.2013.776523","volume":"25","author":"CU Onyike","year":"2013","unstructured":"Onyike, C. U. & Diehl-Schmid, J. The epidemiology of frontotemporal dementia. Int. Rev. Psychiatry 25, 130\u2013137 (2013).","journal-title":"Int. Rev. Psychiatry"},{"key":"577_CR303","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrneurol.2017.75","volume":"13","author":"LH Meeter","year":"2017","unstructured":"Meeter, L. H., Kaat, L. D., Rohrer, J. D. & van Swieten, J. C. Imaging and fluid biomarkers in frontotemporal dementia. Nat. Rev. Neurol. 13, 406\u2013419 (2017).","journal-title":"Nat. Rev. Neurol."},{"key":"577_CR304","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archpsyc.58.4.353","volume":"58","author":"DG Harper","year":"2001","unstructured":"Harper, D. G. et al. Differential circadian rhythm disturbances in men with Alzheimer disease and frontotemporal degeneration. Arch. Gen. Psychiatry 58, 353\u2013360 (2001). This study revealed differences in ciracdian rhythms among individuals with AD, FTD and healthy older individuals.","journal-title":"Arch. Gen. Psychiatry"},{"key":"577_CR305","doi-asserted-by":"crossref","DOI":"10.1007\/s11910-016-0680-3","volume":"16","author":"SJ McCarter","year":"2016","unstructured":"McCarter, S. J., St Louis, E. K. & Boeve, B. F. Sleep disturbances in frontotemporal dementia. Curr. Neurol. Neurosci. Rep. 16, 85 (2016).","journal-title":"Curr. Neurol. Neurosci. Rep."},{"key":"577_CR306","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/13554790903061371","volume":"15","author":"J Merrilees","year":"2009","unstructured":"Merrilees, J., Hubbard, E., Mastick, J., Miller, B. L. & Dowling, G. A. Rest-activity and behavioral disruption in a patient with frontotemporal dementia. Neurocase 15, 515\u2013526 (2009).","journal-title":"Neurocase"},{"key":"577_CR307","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1177\/1533317513494453","volume":"28","author":"A Coban","year":"2013","unstructured":"Coban, A. et al. Reduced orexin-A levels in frontotemporal dementia: possible association with sleep disturbance. Am. J. Alzheimers Dis. Other Demen. 28, 606\u2013611 (2013).","journal-title":"Am. J. Alzheimers Dis. Other Demen."},{"key":"577_CR308","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s40478-019-0845-9","volume":"7","author":"L Dedeene","year":"2019","unstructured":"Dedeene, L. et al. Circadian sleep\/wake-associated cells show dipeptide repeat protein aggregates in C9orf72-related ALS and FTLD cases. Acta Neuropathol. Commun. 7, 189 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"577_CR309","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fnmol.2018.00002","volume":"11","author":"P Vercruysse","year":"2018","unstructured":"Vercruysse, P., Vieau, D., Blum, D., Petersen, A. & Dupuis, L. Hypothalamic alterations in neurodegenerative diseases and their relation to abnormal energy metabolism. Front. Mol. Neurosci. 11, 2 (2018).","journal-title":"Front. Mol. Neurosci."},{"key":"577_CR310","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2018.08.025","volume":"72","author":"T Zhang","year":"2018","unstructured":"Zhang, T. et al. Sleep and circadian abnormalities precede cognitive deficits in R521C FUS knockin rats. Neurobiol. Aging 72, 159\u2013170 (2018).","journal-title":"Neurobiol. Aging"},{"key":"577_CR311","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s40035-018-0131-y","volume":"7","author":"X Jiang","year":"2018","unstructured":"Jiang, X. et al. Neurodegeneration-associated FUS is a novel regulator of circadian gene expression. Transl. Neurodegener. 7, 24 (2018).","journal-title":"Transl. Neurodegener."},{"key":"577_CR312","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13195-020-00651-0","volume":"12","author":"CM Holton","year":"2020","unstructured":"Holton, C. M. et al. Longitudinal changes in EEG power, sleep cycles and behaviour in a tau model of neurodegeneration. Alzheimers Res. Ther. 12, 84 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"577_CR313","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1096\/fba.2019-00042","volume":"1","author":"D Lee","year":"2019","unstructured":"Lee, D. et al. Expression of mutant CHMP2B linked to neurodegeneration in humans disrupts circadian rhythms in Drosophila. FASEB Bioadv. 1, 511\u2013520 (2019).","journal-title":"FASEB Bioadv."},{"key":"577_CR314","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3389\/fnins.2020.00232","volume":"14","author":"M Cassar","year":"2020","unstructured":"Cassar, M., Law, A. D., Chow, E. S., Giebultowicz, J. M. & Kretzschmar, D. Disease-associated mutant tau prevents circadian changes in the cytoskeleton of central pacemaker neurons. Front. Neurosci. 14, 232 (2020).","journal-title":"Front. Neurosci."},{"key":"577_CR315","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1002\/mds.28318","volume":"36","author":"K Mufti","year":"2021","unstructured":"Mufti, K. et al. Comprehensive analysis of familial parkinsonism genes in rapid-eye-movement sleep behavior disorder. Mov. Disord. 36, 235\u2013240 (2021).","journal-title":"Mov. Disord."}],"container-title":["Nature Reviews Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00577-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00577-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00577-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,11]],"date-time":"2024-09-11T17:53:06Z","timestamp":1726077186000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41582-021-00577-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,10]]},"references-count":315,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["577"],"URL":"https:\/\/doi.org\/10.1038\/s41582-021-00577-7","relation":{},"ISSN":["1759-4758","1759-4766"],"issn-type":[{"value":"1759-4758","type":"print"},{"value":"1759-4766","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,10]]},"assertion":[{"value":"4 October 2021","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}